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Abstract
Cardiac rehabilitation (CR) is a secondary prevention program known to
improve clinical outcomes and health-related quality of life in individuals with
cardiovascular disease, yet participation and completion rates are suboptimal.
Additionally, a CR model or models that is/are most efficient for all cohorts of
participants has yet to be established. The purpose of this study was to compare
models of care from four geographically close CR sites that span an international
border through examination of program characteristics and database variables.
Participants were also characterized and examined for potential predictors of
program completion at one site. The most impactful findings were: 1) sites may
want to consider collecting a standardized data battery during programming and
implementing participation incentives to enhance program completion; 2) the
collection of point/date of referral, travel distance, and availability of exercise
equipment at home and gym membership, may want to be considered by all sites;
and 3) increasing age and higher education were associated with program
completion. This research will provide a foundation for comparisons of the
“granular” program and participant details across sites to maximize participant and
program success. As such, the expertise from all sites can be leveraged to lead
discussions that strategize next steps in developing an ideal CR model or models
that not only provide participant benefit, but also cost-efficient programming
solutions.
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Chapter 1: Literature Review
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1.1 Cardiovascular Disease
Cardiovascular disease (CVD) is currently the leading cause of death
worldwide, taking 17.9 million lives in 2016 alone.1 CVD encompasses a group of
disorders that affect both the heart and blood vessels of the heart, brain, and
limbs.1 The majority of CVD-related mortality, however, because of coronary artery
disease (CAD), which is a worldwide epidemic accounting for over nine million
deaths in 2016.2
CAD occurs when blood vessels that lead to the heart are diseased, and it
may also be referred to as: coronary heart disease, ischaemic heart disease,
atherosclerotic heart disease, or simply atherosclerosis.1,2 The pathological
process of CAD is atherosclerosis, which is the formation of fatty deposits or
plaque in the blood vessels that then limits blood flow and causes blood clots.3
Within Canada, the total cost of CVDs in 2005 was approximately $20.9
billion and is predicted to rise to $28.3 billion by 2020.4 CAD remains a major cause
of death in Canada, falling second only to cancer, where approximately 1 in 12 (2.4
million) Canadians equal to or over the age of 20 years lived with CAD in 20122013.5 In the province of Ontario, statistics do not specifically address the
prevalence of CAD, but more than 24,000 Ontarians died in 2012 from CVD.6
Across a national border to the United States, CVD remains the leading
cause of death and it is estimated by 2035 that 45.1% of the adult population (>130
million people) will be diagnosed with CVD, resulting in an annual $1.1 trillion total
cost for CVD.7 CAD currently accounts for 43.8% of the lives lost to CVD in the
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United States and heart disease, which includes CAD is ranked as the
predominant cause of death in many states, including Michigan.7,8
1.1.1 The Pathogenesis of Coronary Artery Disease
The pathological process of CAD, involves atherosclerosis in the coronary
arteries, leading to a myriad of serious, potentially fatal, consequences.
Atherosclerosis affects the layers of the arteries by way of endothelium
dysfunction, the invasion of lipids, pro-inflammatory responses, and the
multiplication/movement of vascular cells.9 To understand the pathological
process of atherosclerosis, it is essential to comprehend the structure of a human
artery.
The arteries in the human body are composed of three layers: the tunica
intima (the inner most layer also known as the endothelium, which houses the
endothelial cells), the tunica media (the middle layer), and the adventitia
(representing the outermost layer).3
In the absence of atherosclerosis and during vascular homeostasis,
endothelial cells interact with the passing blood and keep it in a liquid state.3 A
normal functioning endothelium controls blood clot formation and breakdown by
releasing plasminogen activators and other antithrombotic agents.3 Further, during
vascular homeostasis vasodilators (e.g., nitric oxide [NO]) and vasoconstrictors
are released by the endothelium to maintain equilibrium of the vascular tone.10
Vasodilators cause the blood vessels to widen, whereas vasoconstrictors cause
the blood vessels to narrow.10,11 Thus, during homeostasis a healthy vascular tone
and diameter is maintained.10,11 NO is essential to vascular homeostasis and its
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biosynthesis can become impaired with oxidative stress (i.e., the production of proatherogenic reactive oxygenated species [ROS]).9 The cells responsible for the
maintenance of vascular tone by relaxing and contracting in response to NO are
smooth muscle cells (SMCs), primarily found within the layer of the artery
surrounding the endothelium, the tunica media.3 However, throughout the
atherogenic process, the migration and multiplication of SMCs into the
endothelium supports the formation of atherosclerotic plaque through a series of
steps.3
The pathogenesis of atherosclerosis, and the eventual formation of
atherosclerotic plaque, begins when dysfunction or injury occurs to the
endothelium from the presence of one or more risk factors.3,12 The most common
site of injury involves sections of the arteries that are exposed to augmented shear
stress and disturbed blood flow, such as curvatures and branch points.13 The
immune system responds to these injuries, classifying atherosclerosis as an
inflammatory disease.14 In more detail, pro-inflammatory signaling proteins (i.e.,
cytokines) are released after the initiation of an injury to the endothelium and
increase its permeability.15 This allows for the movement of lipoprotein particles
(i.e., particles that carry cholesterol in the blood), particularly low-density
lipoproteins (LDL), into the sub-endothelium space (Figure 1, #1).3,12,16,17 LDL
undergoes oxidation once in the sub-endothelium space and the oxidized LDL
along with other sources of oxidative stress (i.e., the risk factors discussed in the
subsequent section) further increase the concentration of cytokines (Figure 1, #2).3
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Moreover, cytokines promote the expression of adhesion molecules on the
endothelium as a response to the endothelium injury.15,16 This pro-inflammatory
response attracts immune cells such as monocytes, encouraging the binding of
the immune cells to the expressed adhesion molecules and then the movement of
the immune cells into the sub-endothelium space (Figure 1, #3).3,15,16
Once in the sub-endothelium space, the monocytes are converted to
macrophages, which have scavenger receptors to attach to the oxidized LDL, and
then the macrophages ingest the oxidized LDL (Figure 1, #4).3,16 After the
macrophages consume the oxidized LDL, the macrophages become foam cells,
which further enhance the pro-inflammatory response by releasing more cytokines
(Figure 1, #5).3,16 Foam cells continue to manifest and multiply within the subendothelium space and form the lipid-rich core of atherosclerotic lesions,
commonly referred to as “plaque”.3,16
The lipid-rich core of the plaque becomes surrounded by a fibrous capsule
or cap.3,16 This fibrous structure begins its formation with the movement of SMCs
from the tunica media into the sub-endothelium space, where SMC proliferation is
continued (Figure 1, #6).3,16 The SMCs uptake oxidized LDL and release
extracellular matrix molecules that eventually create the fibrous cap that surrounds
the lipid-rich core of the plaque (Figure 1, #7).3,16 This fibrofatty lesion continues to
become more fibrous, which may occur with endothelial cell and SMC death
(Figure 1, #8).3 Eventually, calcification can occur as well.3
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Figure 1: The Pathogenesis of Atherosclerosis
The green and blue spheres represent cytokines. Modified from Zipes and colleagues.3

As evident by the pathogenic process described above, atherosclerosis is
progressive, with clinical symptoms appearing years after its onset when plaque
formation in the arteries is substantial enough to reduce blood flow.3 Initially, the
artery can compensate for the presence of plaque by remodeling the innermost
layer of the endothelium.18 The two forms of remodeling are negative remodeling,
described by a decrease in the diameter of the artery, and positive remodeling,
which expands the diameter of the artery.18 Negative remodeling is associated with
stable plaque, whereas unstable plaque is prominent with positive remodeling.18
However, the diameter expansion with positive remodeling is eventually inefficient
in preventing blood flow impairments and the unstable plaque associated with
positive remodeling can produce a thrombus due to complications such as the
plaque fissuring, rupturing or eroding.3,19 These disturbances to the plaque and the
ensuing thrombus formation may result in a myocardial infarction (MI).3
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1.1.2 Risk Factors
Modifiable risk factors for CVD, such as physical inactivity and poor diet
have contributed to the increasing prevalence of atherosclerosis.3 Fortunately,
lifestyle interventions (e.g., increasing physical activity) when paired with cessation
of smoking, can reduce the chance of experiencing a secondary vascular event by
approximately 75%.1
The modifiable risk factors for CVD that are influenced by lifestyle
interventions include hypertension (high blood pressure), hyperlipidemia (high
blood cholesterol), diabetes, poor diet, obesity, the use of tobacco, psychological
factors (depression, anxiety, and stress), social factors, and physical
inactivity.1,17,20,21 Unfortunately, some risk factors for CVD are non-modifiable,
including sex, increasing age, ethnicity, and genetics/family history.21,22
1.1.3 Modifiable Risk Factors
The leading modifiable risk factor for CVD is hypertension with 24.1% of
men and 20.1% of women over the age of 18 years diagnosed globally in 2015.1
CAD is a CVD, where the increased pressure on the blood vessels that coincides
with hypertension injures the endothelium and thus makes it more susceptible to
the pathogenesis of atherosclerosis.23 Injury to the endothelium also occurs from
the activation of many cellular signaling pathways that correspond with the
pathogenesis of hypertension, leading to the production of ROS and therefore
oxidative stress, which stimulates the inflammatory response associated with
atherosclerosis.23 Additionally, the bioavailability of NO is reduced from the
hypertension-produced ROS (e.g., superoxide anions), and vascular tone is
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impaired.9,23 However, hypertension and its impact on CAD can be minimized with
various lifestyle interventions such as dietary changes (e.g., adherence to the
Dietary Approaches to Stop Hypertension or the Mediterranean diet, reduced
alcohol consumption, reduced sodium intake), body weight management, smoking
cessation, stress management, and increased physical activity.24,25
Undoubtedly, the pathogenesis of atherosclerosis occurs in the presence of
elevated blood cholesterol levels, thus the modifiable CVD risk factor of
hyperlipidemia, particularly elevated LDL, is imperative to the development of
CAD.3,26 LDL is present for the entire process of plaque development; from subendothelium invasion to the formation of the lipid-rich core of the plaque.3,16
Pharmacotherapy (e.g., statins) is commonly recommended in guidelines for
controlling blood cholesterol levels, but smoking cessation, increased physical
activity, body weight management, and a healthy diet provide favorable blood
cholesterol changes as
well.27–29
Diabetes is also a modifiable risk factor for CVD, but the pathophysiology
between diabetes and atherosclerosis warrants further investigation.9,30 However,
it is understood that hyperglycemia is correlated with oxidative stress (i.e., ROS)
leading to endothelium dysfunction.9,30 It is known that oxidative stress and the
affiliated ROS increase the appearance of cytokines and begin the cascade of
events that leads to the formation of atherosclerotic plaque.3 The detriments of
diabetes can be mitigated with nutritional therapy (e.g., implementing a healthy
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diet while monitoring the intake of carbohydrates), body weight management,
smoking cessation, physical activity, and psychosocial management.31
A poor diet is a modifiable CVD risk factor that can significantly impact the
development of atherosclerosis. More specifically, to control the pathogenesis of
atherosclerosis by lowering blood cholesterol levels (e.g., LDL levels) a limited
dietary consumption of trans fats, saturated fats, and cholesterol is endorsed.27,28
It is also suggested that individuals adopt a Mediterranean or similar diet to reduce
the risk of CVD and related events.27,28 The Mediterranean diet incorporates whole
grains, legumes, fresh vegetables, fruits, nuts, seeds, extra-virgin olive oil,
moderate quantities of fish, low amounts of dairy products, and very low amounts
of red meat, thus a diet opposite to this would be considered unfavourable or a
poor diet for the prevention of CAD.32 Preliminary research demonstrates that
adherence to the Mediterranean diet lowers blood cholesterol levels (i.e., LDL),
decreases oxidative stress while supplying antioxidants, decreases inflammation,
and increases immune function, all representing protective mechanisms against
the development and progression of atherosclerosis.32
Another modifiable risk factor for CVD is obesity. Obesity is accompanied
by an unfavourable amount of adipose tissue, which is recognized as an endocrine
organ that plays a role in the regulation of the endothelium.33 In detail, a high
amount of adipose tissue contributes to the inflammatory response with the release
of pro-inflammatory factors (e.g., cytokines) and the invasion of macrophages,
which both stimulate the pathogenesis of atherosclerosis.33,34 Additionally, pro-and
anti-inflammatory adipocytokines are not produced in balance by adipose tissue
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and can lead to endothelium dysfunction and vascular remodeling.33 Overall,
adipose tissue stimulates an inflammatory response that contributes to the process
of atherosclerosis.34 Fortunately, obesity can be modified, alleviating the effects on
atherosclerosis, with a healthy weight loss program that incorporates a reduced
caloric intake and healthy diet (e.g., the Mediterranean diet).35 Increased physical
activity is also paramount, and other lifestyle interventions (e.g., education, goalsetting, psychological counselling) delivered by a multidisciplinary team that
encourage both diet and physical activity changes.35
Tobacco use (i.e., cigarette smoking) is a modifiable CVD risk factor that
contributes to atherosclerosis during the full duration of its pathogenesis, starting
with injury to the endothelium from the oxidative stress (i.e., the presence of ROS)
caused by cigarette smoke.36 The ROS from the presence of cigarette smoke also
cause the oxidation of LDL, and it has been established that cigarette smoking
increases the concentration of LDL in the blood.36,37 Overall, the release of
inflammatory cytokines is amplified with cigarette smoking promoting the
recruitment of immune cells (e.g., monocytes), and adhesion molecule expression
is intensified, which together allows monocytes to bind and move into the subendothelium space, eventually creating foam cells.3,9,15,16,36 Reduced NO formation
is also associated with cigarette smoking, and thus vasodilation is impaired and
therefore overall vascular homeostasis.9,36 However, with smoking cessation
endothelium dysfunction can be reversed and endothelium function restored, as
seen by the improvement in the vasodilation capabilities of the arteries within only
one-year post-cigarette smoking.36,38 There is a universal consensus in smoking
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cessation (i.e., tobacco cessation) guidelines that individuals should be provided
guidance on how to quit smoking and support through behavioural and
pharmacological treatment.39
Furthermore, psychological factors such as depression, anxiety, and stress,
and various social factors (e.g., social isolation or absence of social support and
integration) are classified as modifiable risk factors for CVD.40,41 Research
examining psychological concerns and CVD is still preliminary with the majority of
studies focusing on depression, suggesting that the presence of depression
increases the inflammatory response.40,42 Similar to depression, anxiety and stress
are also proposed to increase the inflammatory response.40,42 A prevalence of
social factors such as social isolation has also been shown to increase levels of
inflammation, whereas social support and integration decrease levels of
inflammation.43,44 Since atherosclerosis is an inflammatory disease, the activation
of the inflammatory response by various psychological and social factors only
propagate the entire process of plaque formation.14 Suggestions to modify
psychological factors and social factors include increased social support, with
concomitant education on how to manage these factors and establish self-help
strategies.17 Individual or group counselling is beneficial as well to discuss how to
implement lifestyle interventions to manage stress, and improve diet, tobacco use,
and physical activity habits, as psychological factors are interrelated with these
previously mentioned modifiable CVD risk factors.17,40 Moreover, referral to a
mental health specialist may be beneficial for further treatment (e.g.,
psychotherapy) or pharmacotherapy when required.17
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Lastly, the modifiable CVD risk factor of physical inactivity contributes to the
prevalence and severity of many other modifiable CVD risk factors (as mentioned
previously) and to the development of atherosclerosis.45 In regard to the
pathogenesis of atherosclerosis, the lack of shear stress associated with physical
inactivity leads to endothelium dysfunction commencing the atherosclerosis
process.3,45 Moreover, physical inactivity also results in unfavourable levels of
cholesterol in the blood with increased LDL levels contributing to the development
of plaque.3,17,45 Fortunately, the consequences of physical inactivity can be
combatted by simply increasing physical activity levels.45 Shear stress in the
vasculature is increased during bouts of physical activity, stretching the artery
walls, which promotes the health of endothelial cells.45 Additionally, chronic
physical activity positively alters blood lipid levels (e.g., a reduction in LDL levels).45
Chronic physical activity also increases the availability of NO, which promotes
vascular homeostasis as an essential vasodilator.9,46 Additionally, a decrease in
oxidative stress is associated with physical activity by reducing the prevalence of
ROS, even in individuals with CVD, thus diminishing the pro-inflammatory
response by mitigating the release of cytokines and consequently the exposure of
adhesion molecules.46,47 Evidently, physical activity can prevent the occurrence
and progression of atherosclerosis and positivity impact the effect of other
modifiable CVD risk factors as well.
1.1.4 Non-modifiable Risk Factors
As mentioned, not all risk factors for CVD are modifiable. For instance, sex
is one such non-modifiable CVD risk factor.21,22 Both within Canada and the United
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States, CAD is more prevalent in men and appears 10 years earlier than it does in
women.5,7 However, as age increases, the difference in prevalence of CAD
between the sexes narrows, perhaps due to women losing the protective effect of
estrogen after menopause.5 Estrogen is thought to protect women by lowering LDL
levels and SMC multiplication and movement, while promoting vasodilation and
beneficial endothelial cell multiplication and movement.48
Likewise, age is a non-modifiable CVD risk factor.21,22 The natural process
of aging is associated with stiffening of the arteries and endothelium dysfunction.49
As blood vessels age, production of NO is reduced and movement of SMCs into
the sub-endothelium space is common.49 Therefore, when an individual’s age
increases the individual becomes more susceptible to CVD, however by altering
the formerly mentioned modifiable risk factors the influence of aging can be
minimized.50
Within Canada and the United States, there exists discrepancies in the
prevalence of CVD risk factors across different ethnicities.51 This emphasizes the
significance of ethnicity as a non-modifiable CVD risk factor.21,22 For example,
hypertension is more common in Blacks compared to Whites, and diabetes is more
common in Hispanics compared to Whites.51 Diabetes is also more common in
Indigenous peoples compared to Whites, as is abdominal obesity and smoking.51
Compared to Whites, differences have been observed between Arab, Chinese and
Filipino individuals, but the research is limited (compared to that conducted with
Blacks, Hispanics, and Indigenous peoples) to propose a definite difference.51
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Overall, the occurrence of risk factors for CVD events varies amongst ethnicities,
however the reasoning for this requires future investigation.51
Family history increases both the risk and severity of CAD and therefore the
chance of experiencing an MI.52,53 A study by Pandey and colleagues54 defined
premature family history as the occurrence of an MI (e.g., fatal or non-fatal) or a
clinical intervention (e.g., percutaneous coronary intervention [PCI], and/or
coronary artery bypass grafting [CABG]) before 55 years of age in first-degree
relatives who are men, and before 65 years of age in first-degree relatives who are
women. This multi-ethnic study concluded that the incidence and progression of
CAD is correlated with family history, especially if parents and siblings both have
premature CAD.54
1.1.5 Health Complications Associated with Coronary Artery Disease
Many health complications can emerge with CAD and the associated
presence of atherosclerosis. When a thrombus impedes blood flow in a coronary
artery, inadequate amounts of oxygen are delivered to the cardiomyocytes – the
subsequent impairment of blood flow of which is termed myocardial ischemia.3 In
many but not all individuals, a temporary symptom of myocardial ischemia is
angina pectoris, which is pain or discomfort in the chest and adjacent areas (e.g.,
neck, jaw, arms and the abdomen).3 However, the exact location, severity, and
duration of angina pectoris can vary drastically between individuals, particularly in
women.3,55,56 Typical or stable angina pectoris is usually stimulated by over
exertion and is relieved quickly by rest and short-acting nitroglycerin.3 Dissimilarly,
unstable angina pectoris is more severe and unpredictable, occurring at rest or
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while sleeping, and relief from rest and nitroglycerin is delayed.3 In approximately
one third of individuals treated for ischemia, no symptoms are present, and this is
known as silent (asymptomatic) ischemia and therefore lacks warning signs of the
condition.3
Furthermore, when a thrombus impedes the blood flow in a coronary artery
and myocardial ischemia is not reversed or blood flow restored, an MI can develop
and if long or severe enough, can cause cardiomyocyte death.3,57 The most recent
universal definition of MI incorporates five types: spontaneous MI, MI secondary
to an ischaemic imbalance, cardiac death due to MI, MI associated with a PCI, and
MI associated with CABG.57 Spontaneous MI would be the appropriate
classification if an individual had CAD, formed a thrombus, and suffered an MI.57
In contrast, the classification of MI secondary to an ischemic imbalance is used
when CAD is not the cause of a thrombus and restricted blood flow, and some
other condition causes the blood flow impairment, such as a coronary artery
vasospasm.57
In addition to the five types of MI, an individual can be diagnosed with acute
coronary syndrome (ACS) when the individual initially presents with symptoms of
an MI or if the severity of the individual’s symptoms worsens.3 Myocardial ischemia
can result in stable angina pectoris, but it can also cause ACS, which is subdivided
into unstable angina pectoris, non-ST-segment elevation MI (NSTEMI), and STsegment elevation MI (STEMI).3 The characteristics of the thrombus differ for the
classifications of ACS, where unstable angina pectoris and NSTEMI usually
involve a thrombus that is incomplete, dynamic, or absent, and an occlusive
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thrombus is usually present with STEMI.9 This relates to the severity of the
diagnosis: STEMI correlates with cardiomyocyte death from an occlusive
thrombus; acute occlusion or incomplete occlusion correlates with NSTEMI; and
even less severe occlusion correlates with unstable angina pectoris.9
While NSTEMI and STEMI both present with clinical symptoms and cardiac
biomarker changes (i.e., increase in cardiac troponin in the blood) that are
suggestive of a cardiomyocyte/myocardium death, a 12-lead electrocardiogram
(ECG) can be used to determine if the ST segment of the cardiac cycle is
elevated.3 This is how the distinction between NSTEMI and STEMI is made;
NSTEMI is not typically associated with an elevated ST segment, whereas STEMI
is associated with an elevated ST segment .3 Furthermore, clinical symptoms can
also be the same for unstable angina pectoris, however a normal ECG may (i.e.,
no changes in the ST segment) exist and there is no elevation of cardiac
biomarkers (i.e., cardiac troponin) indicating myocardium death.3
Alternatively, a health complication that manifests with end-stage CAD (with
or without the occurrence of an MI) is heart failure accompanied by left ventricular
systolic dysfunction.9 The progressive disorder of heart failure originates when
damage to the myocardium is induced.3,9 Tissue damage experienced from
myocardial ischemia reduces the heart’s contractibility, therefore the heart tries to
adapt by modifying the left ventricle (e.g., left ventricle hypertrophy) to maintain
pumping capacity and systolic function, but there is ultimately impaired ventricle
filling and emptying.3,9,58 Notably, the presence of diastolic dysfunction coexists to
some extent with systolic dysfunction.9 The cardiovascular system puts forth
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adaptations (e.g., blood volume, vascular, neurohormonal) in an attempt to
maintain cardiac output, however these compensations are not entirely efficient
and over time the disease progresses.9
Moreover, heart failure can be classified in terms of ejection fraction. Firstly,
there is heart failure with a preserved ejection fraction (HFpEF), where the left
ventricle can eject 50% or more of the blood it is supplied.3 Secondly, there is heart
failure with a reduced ejection fraction (HFrEF), where the left ventricle ejects less
than 40% of the blood it is supplied.3 Notably, heart failure with a mid-range
ejection fraction (HFmrEF) is where the left ventricle can eject 40-50% of the blood
it is supplied.3 It is important to note that CAD (i.e., impaired blood flow or an MI)
is the primary cause of heart failure in industrialized countries.3 Moreover, CAD
accounts for more HFrEF than HFpEF cases, whereas HFpEF often results from
systolic hypertension.59,60
Previously, acute heart failure was thought to be part of the progression of
heart failure, but it is now recognized as its own disorder.3 Generally, the diagnosis
of acute heart failure is applied when an individual requires immediate medical
attention due to the exacerbation of heart failure symptoms, whether the symptoms
are reoccurring or appearing for the first time.3 Despite the presence of the word
“acute”, the exacerbation of the symptoms may happen over time, and eventually
may be amplified enough to require medical attention.3
The myocardial ischemia and cardiomyocyte death experienced with MI can
cause electrophysiological changes within the heart.61 Consequently, cardiac
arrhythmias can occur when the electrical activity of an atrium or ventricle is
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irregular, negatively affecting the heart rate and cardiac output and potentially
causing cardiac arrest if the electrical activity is not normalized.62 If an arrhythmia
causes the heart rate to be too slow, it is termed a bradyarrhythmia, whereas a
heart rate that is too fast is labeled as tachyarrhythmia.9 Arrhythmias, especially
those related to the ventricles, are frequently associated with the myocardial
ischemia experienced with CAD, and MI.9 Ischemic tissue and the production of
scar tissue after MI can block electrical propagation in the heart causing the
electrical impulse to reroute itself around the barrier (i.e., the ischemic tissue and
scar tissue), which is known as re-entry and is most often associated with
tachyarrthymias.9 Ventricular arrhythmias such as ventricular tachycardia are
common after an MI and can progress into ventricular fibrillation, and potentially
sudden cardiac death.9 Arrhythmias known as “heart blocks” can result from
ischemic cardiomyocyte damage as well and involve the atrioventricular electrical
propagation being impaired.9
Sudden cardiac death is the most severe consequence of an MI, heart
failure or a cardiac arrhythmia.3 Sudden cardiac death (i.e., cardiac arrest) has
been defined by Zipes and colleagues3 as “natural death from cardiac causes
heralded by abrupt loss of consciousness within one hour of the onset of an acute
change in cardiovascular status”. Overall, the cause of death is related to cardiac
dysfunction, is unexpected, rapid, and considered natural.3
1.1.6 Surgical Interventions Associated with Coronary Artery Disease
Surgical interventions are often required for CAD. If an individual suffers
from CAD, PCI (please refer to section 1.1.4) can be performed to mitigate the
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presence of plaque in the arteries to relieve symptoms and improve the probability
of survival.3,63 The coronary arteries are accessed by inserting a catheter through
the femoral, brachial, or radial artery.3 Once the catheter has reached the affected
coronary artery, different methods are used to expand (e.g., balloon angioplasty)
or support via stents (e.g., bare-metal or drug-eluting) the coronary lumen or to
remove the plaque (e.g., coronary atherectomy).3,63
Depending on the complexity of the diagnosis, CABG (please refer to
section 1.1.4) may be the more appropriate revascularization procedure.20 The
gold standard for CABG is to induce cardiac arrest in the individual, then conduct
an on-pump CABG to control hemodynamics while operating.64 On-pump CABG
involves cross-clamping the aorta and bypassing the cardiopulmonary system to
control hemodynamics.65 Alternatively, CABG can be performed on a beating
heart, which is known as off-pump CABG and uses tactics to minimize cardiac
motion.64 A median sternotomy is the most efficient incision technique to access
the heart; however, other methods have evolved such as the less invasive
endoscopic method with robot assistance.64 As the name implies, new routes for
arteries or veins are grafted to bypass the affected coronary arteries and improve
blood flow.64 CABG is recommended to improve survival when there is greater
than or equal to 50% stenosis in the left main coronary artery however, there are
exceptions for when PCI may be preferred.63,64 CABG is also recommended to
improve survival when greater than or equal to 70% stenosis occurs in three major
coronary arteries, or when it occurs in one major coronary artery plus the proximal
left anterior descending artery.63,64
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When there is greater than or equal to 70% stenosis, PCI or CABG can
improve survival for individuals with sudden cardiac arrest who are suffering from
ventricular tachycardia due to myocardial ischemia.63,64 Additionally, when an
individual is expected to positively respond to revascularization, and if other
medical interventions have not relieved unacceptable levels of angina, PCI or
CABG can be performed when 1 or more coronary arteries have greater than or
equal to 70% stenosis to improve symptoms.63,64 PCI or CABG can also be
performed to treat ACS.63,64,66 In individuals with unstable angina pectoris and
NSTEMI, the purpose is to relieve symptoms, reduce the occurrence of an MI, and
prevent death.63,64,66 Moreover, in individuals with STEMI, PCI and CABG can also
be performed to reduce complications and death.63,64,66 Overall, the choice
between PCI and CABG to treat CAD and its complications is specific to the
individual with many factors to be considered.63,64,66
If the issue concerns the electrical function of the heart, an implantable
electronic device can be inserted subcutaneously below the clavicle.12 To maintain
atrioventricular synchrony, a permanent pacemaker is implanted with leads placed
in the right atrium and right and/or left ventricle to sense and restore electrical
activity.12 Comparatively, an implantable cardioverter- defibrillator has leads that
innervate the heart transvenously to detect fatal ventricular tachyarrhythmias and
regain proper pacing, or provide defibrillation if necessary.12
Ultimately, in instances where surgical interventions do not relieve
symptoms and end-stage heart failure is present, an orthotopic heart transplant
may be required.12
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1.1.7 Pharmacotherapy Associated with Coronary Artery Disease
The administration of cardioprotective medications can be effective in
preventing and treating CAD as well.20 Beta blockers are a class of drugs that lower
heart rate and blood pressure levels to help treat CAD.20 Angiotensin-converting
enzyme inhibitors and angiotensin-receptor blockers are other classes of drugs
prescribed for CAD to dilate the arteries.20 By dilating the arteries, angiotensinconverting enzyme inhibitors and angiotensin-receptor blockers lower systemic
blood pressure and the pressure in the heart, preventing the heart from
overworking.20 Consequently, the heart can recover from an MI, there is a
decreased risk for arrhythmias, and cardiac dysfunction due to heart failure is
improved.20 Additionally, the class of drugs known as platelet inhibitors limit platelet
aggregation and decrease inflammation, therefore this class of drugs may be
prescribed for CAD treatment.20 Since this class of drugs prevents the formation
of a thrombus, they are usually prescribed after a PCI to prevent a thrombus from
forming in a stent.20 Another vital class of drugs for prevention and treatment of
CAD are statins, which lower blood cholesterol levels, decrease inflammation, and
promote the thickening of the fibrous cap; all important approaches to preventing
plaque disturbance and its resulting consequences.20
1.1.8 Lifestyle Interventions for Coronary Artery Disease
While surgical interventions and pharmacotherapies are prevalent in
cardiology, it has been apparent for many years that the field should be integrative
by emphasizing disease prevention and lifestyle interventions to improve medical
care and outcome.3,67 The terms integrative cardiology or preventive cardiology
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describe this ideology of care and are greatly shaped by the CVD risk factors
established by the Framingham Heart Study.3,67 Essentially, the main objective of
integrative cardiology is the prevention of disease, where the care provided models
guidelines, but individuals also possess control to develop goals and therapeutic
plans in synergy with healthcare providers.3 Integrative cardiology exceeds
traditional standards of care in cardiology by emphasizing therapeutic plans that
incorporate lifestyle interventions to yield the greatest outcomes for individuals by
reducing the burden of CVD risk factors.3
Cardiac rehabilitation (CR) is an ideal example of integrative cardiology.68
CR is a secondary prevention strategy delivered by a multidisciplinary team of
health professionals, with a focus on lifestyle interventions (e.g., tobacco
cessation, exercise training, and nutritional counselling) to manage the modifiable
risk factors associated with CVD and ultimately CAD.69 CR aims to improve the
overall well-being of participants, including physical, psychosocial, and vocational
success.17,22
1.2 Cardiac Rehabilitation
1.2.1 Benefits of Cardiac Rehabilitation
A recent Cochrane Systematic Review and meta-analysis (63 randomised
controlled trials; 14,486 participants) provided evidence that exercise-based CR
(primarily aerobic training; median intervention length of six months), compared to
usual care (standard medical care with no form of exercise prescription and
guidance), reduced cardiovascular mortality and the overall risk of hospital
admissions.68 However, these benefits did not translate into a reduction in all-
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cause mortality.68 Due to the variance in health-related quality of life (HRQoL)
measures, a meta-analysis was not conducted on this parameter, but in those
studies including HRQoL there was evidence of improvement following exercisebased CR participation.68
It is important to note that the trials included exercise-only interventions and
interventions employing more comprehensive secondary prevention strategies
(i.e., exercise, educational, and psychosocial components).68 The level of
supervision varied (i.e., unsupervised or supervised) as did the location of the
interventions (i.e., inpatient, outpatient, community-based, or home-based).68 The
incorporated trials were primarily located in Europe (59%; 37 studies) with nine
trials conducted in the United States and three in Canada.68 Furthermore, less than
15% of the participants were women with the sample primarily representing
younger men post-MI or revascularization surgery.68
Recently, the aforementioned work was scrutinized for its inclusion of out of
date trials. Therefore, Powell and colleagues70 revised the Cochrane Systematic
Review and meta-analysis by Anderson and colleagues68 and focused on more
recent trials to include only those occurring in the last two decades to represent
the time period of surgical and pharmacological advancements for CVD. Similar to
Anderson and colleagues68, exercise-based CR did not reduce all-cause
mortality.70 However, in contrast to Anderson and colleagues68, reduction in CVD
mortality was no longer significant, but the authors did note a minimal reduction in
hospital admissions.70

23

These findings were met with resistance from the international CR
community, with investigators around the world questioning the legitimacy of the
work. An editorial was published in response to Powell and colleagues70 and
implied that Powell and colleagues’ search tactics did not guarantee that the
included trials addressed all core components of CR, and in modern CR it is
exercise in conjunction with the other core components that yields the greatest
benefits.71 It is also important to understand the context in which the exercise
interventions were applied because many factors (e.g., personal, environmental,
organizational, professional) can influence the measured outcomes, and perhaps
certain components of the intervention are not as beneficial in specific
circumstances.71
Very recently, a systematic review of CR meta-analyses (published prior to
2012) of individuals with CAD or heart failure was conducted to determine the
statistical and clinical (e.g., minimal important difference in a domain that an
individual considers important and that would encourage clinicians to
recommended CR as part of the individual’s treatment plan) evidence for CR
outcomes.72 The meta-analyses included mostly centre-based supervised
exercise interventions (87%; thus home or telemedicine based CR was
underrepresented), and typically included aerobic and/or resistance training, with
or without psychosocial and/or educational interventions.72 It was determined that
the majority of the studies reported statistical as opposed to clinical significance,
therefore lacked practical or clinical importance (e.g., minimal important
difference), which is important to determine when encouraging CR referral and
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enrollment by clinicians and their patients, respectively.72 Additionally, similar to
the previously mentioned studies, there was little impact of CR on all-cause
mortality, but a reduction in cardiovascular mortality was observed.72 Future
research is warranted to determine the impact of modern medical management on
all-cause mortality and the potential confounding role in CR-driven benefits.72
Nonetheless, exercise as a cornerstone component for CR has
demonstrated many clinical benefits. Increased cardiorespiratory fitness from
aerobic training in CR is correlated with a reduction in blood pressure, visceral
adiposity and systematic inflammation, and improved insulin sensitivity,
endothelial function and psychological stress.73 Moreover, a combination of
resistance and aerobic training in CR results in a greater decrease of body fat
percentage and greater increases in quality of life, maximal oxygen consumption,
fat-free mass, and both upper and lower body strength, compared to aerobic
training alone.74
In a related systematic review and meta-analysis, investigators sought to
expand the exercise only focus and included recent randomised controlled trials
that involved interventions beyond exercise to incorporate other key secondary
prevention strategies as well.75 van Halewijn and colleagues75 determined that the
risk of MI as well as cerebrovascular events were reduced by comprehensive CR.
Comparable to Anderson and colleagues68, CR did not decrease all-cause
mortality, but did reduce cardiovascular mortality.75 An important finding of this
work was the observed relative reduction in all-cause mortality with cardiac
rehabilitation programs (CRPs) that addressed six or more risk factors, compared
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to those that addressed less than six risk factors.75 This finding supports the
previous work of Rauch and colleagues76, emphasizing the importance of a multicomponent CRP for CVD treatment.75 As such, there is a demand for further
research regarding the effect of individual CR components and the collective effect
on clinical outcomes.77,78
1.2.2 History
CR has been evolved over the last century. In the 1860’s immobilization
was considered the most valuable treatment for MI because it was presumed to
allow the heart to recover naturally.79 Accordingly, in the 1920’s individuals who
suffered from an MI were urgently confined to bed rest as recovery of the heart
was still presumed to be correlated with ample physical rest.80,81 The optimal
duration of bed rest was at least a month and prolonged for symptomatic
individuals, whose ordinary lives were encouraged to be delayed if required.80
Thus, bed rest remained the predominant rehabilitation treatment for MI, enduring
for nearly four decades.82
During the 1950’s the validity of prolonged bed rest as a treatment for MI
was disputed. Accumulating evidence suggested that it was unnecessary, as well
as potentially detrimental to an individual’s physical and mental health.83,84 With
this new stance, chair treatment or the “cardiac chair” began to evolve, which was
predicted to be a superior method for resting the damaged heart.84 More
specifically, within two days of an MI, individuals were transferred to a chair and
later returned to bed when fatigue occurred.84,85 Individuals eventually remained in
the chair for the better part of the day and around the third or fourth week the
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individuals began to take steps.84,85 This new form of treatment overthrew the
impression that heart rupture or death would occur if the individual did not remain
on bed rest.79 In reality, when compared to bed ridden individuals, those who
underwent chair treatment during hospitalization had increased physical and
psychological health, demonstrating a promising rehabilitation process that
included mobilization.85–87 Eventually, it was demonstrated that participation in
endurance activities such as swimming and hiking was “cardioprotective” and
“rehabilitative”, revealing the necessity of not only mobilization, but exercise of all
intensities in the rehabilitation process of the individual.88
The goal of rehabilitation for individuals with cardiac events or conditions
expanded beyond simply having the individuals discharged from the hospital, but
also focused on equipping the individuals to excel in everyday life, including
vocationally.87,89 The early objective of rehabilitation was to simply regain regular
physical activity and independence.90 However, addressing all aspects of the
individual’s life (e.g., physical and psychological well-being) and not solely
economic success was said to allow an individual to live a fulfilled life.87,89 This
new model of rehabilitation involved a non-hierarchal multidisciplinary team that
provided an individualized program to the most significant member of the team,
the individual with a cardiac event or condition.87,89 In essence, CR expanded
beyond only exercise as treatment for the individual to encompass other secondary
prevention strategies like those found in the modern CRP, such as health
behaviour change and education, cardiovascular risk factor management, and
cardioprotective therapies.22,91
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1.2.3 Eligibility
Recently, an international organization, the International Council of
Cardiovascular Prevention and Rehabilitation was founded to create a more
homogenous model of CR around the world.92 At this time, the International
Council of Cardiovascular Prevention and Rehabilitation is too new to provide
global CR guidelines, however the council endorses the recent review of
international CR guidelines by Price and colleagues.92,93
As indicated by Price and colleagues93, the eligibility for CR is relatively
standard throughout the world with a few nuances between countries: MI, unstable
angina, stable angina, asymptomatic CAD, revascularisation procedures, cardiac
valve surgery and other cardiac surgeries, pacemaker or implantable cardioverterdefibrillator insertion, atrial fibrillation, chronic heart failure, cardiomyopathy,
rheumatic and congenital heart disease, cardiac transplantation, peripheral arterial
disease, pulmonary hypertension, post cerebral vascular disease, and individuals
with a high risk of developing CVD.
If the focus is narrowed to specific countries, in Canada, the Canadian
Association of Cardiac Rehabilitation or more recently named, the Canadian
Association of Cardiovascular Prevention and Rehabilitation (CACPR) is
responsible for national CR guidelines, including eligibility criteria, with provincial
organizations such as CorHealth Ontario (previously the Cardiac Care Network
(CCN)) supplying the latest guidelines. In Canada, individuals diagnosed with an
MI or ACS, chronic stable angina pectoris, or heart failure, or who have undergone
revascularisation procedures (e.g., PCI or CABG), cardiac resynchronization
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therapy, cardiac valve surgery, or a cardiac transplantation are most commonly
referred to CR.22 However, the provincial level guidelines in Ontario, while following
the national referral eligibility recommendations, also suggest that if CVD risk
factors (e.g., hypertension, dyslipidemia) are prevalent then an individual should
be referred to CR even if the individual has not yet had a CVD event.91
In the United States, eligibility for referral to CR is nearly identical to
Canadian guidelines, with the exception that the United States guidelines do not
mention a referral to CR following cardiac resynchronization therapy, or if CVD risk
factors are prevalent but a CVD event has not yet occurred.17,94,95 The association
in the United States that provides national CR guidelines is the American
Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). Likewise,
the American Heart Association (AHA) and the American College of Cardiology
(ACC) are also legitimate resources.
1.2.4 Inpatient Cardiac Rehabilitation
The progression of CR is standard throughout the world, beginning with a
hospitalization for a coronary event, followed by a recovery period, and then ongoing rehabilitation and maintenance, although slight nuances may exist within
each component.93 There are three common phases of CR: inpatient CR, early
outpatient CR, and long-term outpatient or maintenance CR.22 After the
stabilization and treatment of an acute coronary event the initiation of CR may
commence with inpatient CR, additionally, the CACPR suggests that inpatient CR
may commence before procedures such as PCI and CABG if these procedures
are prearranged.17,22
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The preamble to inpatient CR is a chart review and a detailed interview to
assess the individual’s medical history before beginning the core elements of
inpatient CR, including physical activity progression and education.17 The rate of
progression for mobilization and physical activity will be dependent on each
individual’s diagnoses with some advancing more rapidly than others.17 When an
individual shows a willingness to learn then education on CVD risk factor
management and self-care should promptly begin focusing on the individual’s
personal interests, but always addressing information related to their safety as
well.17
The qualified individual who delivers inpatient CR may be a nurse,
occupational or physical therapist, exercise specialist, or another staff member
who specializes in CR.17 The location of implementing inpatient CR can differ;
most often taking place in an individual’s room or care unit, mobilization and
physical activity can also occur in hospital hallways or in inpatient exercise
rooms.17 In some instances, there may be a specific room dedicated to inpatient
CR where individuals can undergo assessments, educational sessions and
mobilization activities to become prepared for discharge, and referral to early
outpatient CR.17 The CACPR and AACVPR concur it is the responsibility of the
inpatient CR health professional to create a discharge plan for individuals, educate
the individuals about early outpatient CR, and refer individuals to early outpatient
CR before hospital discharge.17,22
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1.2.5 Referral Process
Referral to early outpatient CR is the initial step for outpatient CR
enrollment, incorporating an order for CR based on the individual’s medical record,
a conversation between a health professional and the individual about CR, and
finally a CRP receiving information regarding the referral.96 The CACPR and
AACVPR both highlight the importance of health professionals endorsing early
outpatient CR enrollment for eligible inpatients to encourage participation.17,22
Furthermore, if within the previous year an individual received an eligible diagnosis
for referral to CR in the outpatient setting, a physician or another cardiac health
professional is responsible for referring the individual to early outpatient CR if the
individual has not previously participated.17,22
In Canada there is a benchmark of 30 days to enroll an inpatient in early
outpatient CR after hospital discharge, and in the province of Ontario, within two
weeks of receiving the referral, it is the CRP’s responsibility to contact the
individual to schedule an intake appointment.91,97 Similarly, in the United States it
is recommended that 1 to 3 weeks after inpatients are discharged from the hospital
early outpatient CR should commence, with a benchmark for time to enrollment of
21 days post hospital discharge.17,95
The traditional or “usual” procedure for referral to CR is non-systematic and
relies on the discretion of the physician to recommend CR and complete the
referral.98,99 However, it is highlighted by the CACPR and AACVPR that automatic
referral procedures should be implemented to maximize referral rates, rather than
usual referral procedures.17,22 In fact, it has been demonstrated that individuals
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have a greater probability of being referred to CR when automatic referral
procedures are employed.98–100 Automatic referrals are systematic and may
involve electronic medical records, where a referral to CR is the default on order
sets that healthcare professionals must uncheck, or a referral may be automatically
sent to the CRP according to codes entered into a medical record to describe the
individual’s health status.100,101 Additionally, an automatic referral may be paperbased and included with hospital discharge order sets, then faxed to CR sites after
completion.100,101 Notably, switching from manually faxed paper forms for
automatic referral to an electronic system has been shown to increase the number
of inpatient referrals by 17-fold.102
Unfortunately, referral rates in both Canada and the United States remain
suboptimal, but it has been recognized that strategies need to be employed to
drastically increase referrals to CRPs.96,103 One of the key barriers for referrals is
the referring physician, who may pose as a hinderance for various reasons, such
as lack of endorsement or educated promotion of CR to patients.104–106
Fortunately, automatic referral procedures in conjunction with a liaison to
discuss CR with the individual before discharge can increase referrals rates to
85.8%, compared to 70.2% for only automatic referral procedures.99 This
emphasizes the importance of automatic inpatient referral systems and liaisons to
educate and refer an individual to outpatient CR, and the combination of these two
strategies to overcome barriers such as lack of physician endorsement to improve
referral rates to early outpatient CR.96,99
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1.2.6 Barriers to CR Participation
Even if optimally referred, there are many barriers that prevent individuals
from participating in CR. Thus the utilization and completion rates for CR in both
Canada and the United States remains suboptimal, requiring substantial
improvement.96,103 Specific cohorts of individuals are less likely to participate in CR
including women and older individuals.107–112 It has also been suggested that
socioeconomic status and race or ethnicity influence participation rates, where
individuals with a lower socioeconomic status (i.e., lower education, unemployed,
lower income) and who identify as a minority are less likely to engage in CR.107–
110,113,114

Additionally, individuals with more comorbidities, and those who have

been referred for an indication other than CABG are less likely to participate.
110,112

107–

Moreover, studies examining these factors provide contrasting results or

were not sufficiently comprehensive and hence warrant further consideration in the
modern era of CR.109
Furthermore, individuals may not participate in CR due to accessibility
issues (e.g., transportation and travel distance), time availability, and the cost of
CR, the latter of which is particularly relevant in countries such as the United
States.107,115 Conclusively, the CRP itself can be restrictive as well if services are
limited due to facility or financial constraints.103
Strategies have been suggested by Ades and colleagues96 to overcome
these barriers and improve utilization and completion rates for CR. For instance,
offering gender-tailored programming, reducing the financial expense for
individuals, providing flexible hours of programming (e.g., after work and weekend

33

hours), evaluating performance measures to improve services offered, and
incentives for participating (e.g., motivational, financial) are a few of the strategies
proposed to improve utilization and completion of CR.96
1.2.7 Intake Assessment
Following a referral to early outpatient CR, initial contact by the CRP, and
the completion of an intake appointment, an intake assessment including a medical
and physical evaluation is common internationally prior to beginning early
outpatient CR.93 Within the Canada and the United States, guidelines regarding
the intake assessment are similar.17,22,91 Moreover, the data collected during the
intake assessment is important to revaluate periodically throughout the duration of
early outpatient CR and at program completion to monitor progress.17,22
Using information obtained during the intake session, together with other
clinical variables (e.g., cardiorespiratory fitness, metabolic fitness), an intake
assessment determines the participant’s risk for another cardiac event and is
especially relevant during the exercise component of CR.17,22,91 It is preferred that
the medical and physical evaluations be performed by a physician or other health
professional with CVD experience.17,22 Following the intake assessment, an
individualized care plan can be developed that aligns with the participant’s goals
and provides self-managing strategies to reduce the participant’s risk of
CVD.17,22,91
Firstly, the medical history should focus on the status of the participant’s
CVD, including the participant’s risk factors and how the risk factors are being
managed

to

allow

for

the

appropriate
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lifestyle

modification

recommendations.17,22,91 The medical history should include past and present CVD
symptoms, diagnoses, hospitalizations, and surgical procedures, as well as
medications, risk factors for atherosclerotic disease progression, family history,
and comorbidities.17,22,91
Additionally, information should be recorded on dietary content and eating
habits, sleep habits, physical activity or exercise patterns, alcohol consumption,
emotional and psychosocial health, and tobacco use.17,22,91 It is also advantageous
to address demographic information and other influences on health that may pose
as a barrier to CR participation such as sex, age, race or ethnicity, socioeconomic
status (i.e., level of completed education, employment circumstances, financial
situation), and social support.17,22,91
Secondly, the physical evaluation should assess the following: vital signs
(e.g., pulse rate and blood pressure), anthropometrical measurements,
cardiovascular status, respiratory status, musculoskeletal status, procedurerelated issues, and function of the lower extremities.17,22,91 Laboratory results
including a lipid profile, glucose and glycosylated hemoglobin (HbA1c)
measurements, and a resting 12-lead ECG are essential components of the intake
assessment as well.17,22,91
If the medical and physical evaluations deem it safe for a participant to
exercise, an exercise stress test protocol will be conducted to estimate the
participant’s cardiorespiratory fitness level (i.e., functional capacity; maximal
oxygen consumption [VO2]).17,22 An ECG-monitored graded exercise test can be
used as a functional assessment tool to determine cardiorespiratory fitness, and
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therefore help administer a safe and individualized exercise program.17,22,91 Very
recently, the AACVPR stated that the most accurate exercise prescription can be
recommended when a symptom-limited graded exercise test is conducted prior to
CR

participation,

which

coincides

with

CACPR

recommendations.22,116

Nonetheless, an exercise protocol should be determined on an individual basis as
there are many protocols available to measure both submaximal (i.e., to estimate
maximal VO2 by use of equations) and maximal VO2 depending on individual
factors (e.g., disease status, age, estimated physical fitness level).3 However,
although not as validated, another assessment such as the six-minute walk test
can be used when graded exercise tests are unavailable or for participants with
other limiting factors.17,22,91 Additionally, metabolic fitness (i.e., the effect of CVD
risk factors) can be predicted by using measures such as the Framingham risk
assessment tool.17,22
1.2.8 Outpatient Cardiac Rehabilitation
After completion of the intake assessment, the early outpatient CR phase
commences. The standard duration is six months in Canada, with an average of
two onsite sessions per week.22 While Canada does have a publicly funded health
care system, early outpatient CR funding varies by province.103,117 Within Ontario
the fee for early outpatient CR is typically covered by the Ontario Ministry of Health
and Long-term Care following the success of a 2001 CR pilot project in Ontario
that demonstrated the value of CR.118
In the United States, 36 onsite sessions is the standard, commonly three
times per week for a total of three months of early outpatient CR, which may be
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publicly funded (e.g., Medicare for participants greater than 65 years of age) or
privately funded (e.g., purchased health care insurance), however, participants
may still need to provide co-payments for each visit even if insured.17,96,119,120
Evidently, if participants do not qualify for public funding or hold private funding,
the participant may pay for CR entirely out-of-pocket.
Once an individual is enrolled in early outpatient CR a customized,
multifaceted, evidence-based intervention will be designed to meet the individual’s
needs.17,22 In both Canada and the United States, the core components of
outpatient CR are: intake assessment, risk factor modification and health
behaviour interventions (nutritional counselling, lipid management, weight
management, hypertension management, diabetes management, adherence to
appropriate pharmacotherapy, tobacco cessation, psychosocial management, and
physical activity counselling), and exercise training.17,22
In Canada, the CACPR takes it one step further to also include, a systematic
referral process, program adaptations for underserved populations, growth of selfmanagement techniques for participants, and leisure time activities as core
components.22 The other core components stated by the CACPR are programs to
assess outcomes, performance measures, quality improvement, and professional
development to constantly improve program delivery.22
The province of Ontario has an even more comprehensive description,
stating three core CR components of: health behaviour change and education,
cardiovascular risk factor management (physical activity, nutrition, tobacco use,
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psychological/psychosocial health, hypertension, dyslipidemia, dysglycemia), and
lastly cardioprotective therapies.91
While all the components mentioned by the CACPR are important to
address, the AACVPR and CCN provide more up to date, simplistic core
components, and address all other components mentioned by the CACPR
elsewhere in the published guidelines. Nonetheless, the overall goal of outpatient
CR is to provide lifestyle management counselling and education to encourage
behaviour changes that may prevent a secondary cardiac event.121
The core components of CR are fulfilled by having a multidisciplinary team
of staff members.17,22 A medical director who is a physician is required, but other
key personnel may include: registered nurses, exercise specialists, exercise
physiologists, physical therapists, respiratory therapists, registered dietitians,
mental health professionals (e.g., psychologist, social worker, or psychiatrist),
health educators, occupational therapists, vocational rehabilitation counselors,
clinical pharmacists, cardiovascular technicians, and other physicians.17,22 The
multidisciplinary team allows for all-encompassing lifestyle alterations that will
hopefully result in favourable and permanent behaviour changes.122
Three main models of early outpatient CR delivery exist. The most
traditional model involves supervision by the staff members previously mentioned,
and the location is centre-based within the community (e.g., located in a hospital
physiotherapy centre or university gymnasium).17,91,123 Centre-based deliverance
of CR is appropriate for high-risk participants (as determined previously through
risk stratification protocols) who require supervised exercise training.22
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Nevertheless, alternative models of early outpatient CR have been introduced to
increase participation rates.17,22,123
Two alternative or complementary models to centre-based CR are homebased and hybrid programming.17,22 Once deemed safe, following risk
stratification, participants can engage in home-based CR, which involves the
majority of the participants’ exercise training completed without direct
supervision.17,22 A home-based model limits the amount of on-site sessions
required, but still maintains communication with the participant (e.g., telephone
calls, regular mail) and provides follow-ups with an exercise specialist to monitor
the participant’s exercise prescription.22
The hybrid model serves as a transition from centre-based to home-based
CR, involving both on-site (at least once per week) and home-based exercise
training to monitor a participant’s safety.22 In both the home-based and hybrid
model, the CR components beyond exercise training are still addressed, and thus
the models serve as alternative outpatient CR models to overcome participation
barriers (e.g., transportation, work commitments).22,124 It has been demonstrated
that there are no significant differences for total mortality, exercise capacity, or
HRQoL

between

these

complementary

models

and

centre-based

CR,

emphasizing the potential of the complementary models to increase participation
rates.123–125
1.2.9 Maintenance Cardiac Rehabilitation
The maintenance phase, recommended internationally, follows the early
outpatient phase for participants who want to continue managing CVD risk
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factors.17,22,93 The maintenance phase is comparable to the early CR phase, where
the CRP is most often located within a hospital or elsewhere in the community.17,22
Patients continue to complete an individualized secondary prevention program;
however, there is usually less interaction with CR staff members than that received
during initial CR programming.17
1.3 Cardiac Rehabilitation Exercise Prescription
Exercise training is a core component of CR around the world.93 In general,
exercise-based CR is considered safe because of the intensive risk factor
stratification that occurs in the previously mentioned intake assessment.17,22
Moreover, it is safe in both the early outpatient and maintenance phase of CR.126
Overall, the frequency, intensity, time, type, volume, and progression of
exercise should be included in an exercise prescription for all CR participants.116
To ensure participants are fully experiencing the benefits of CR, a participant’s
exercise prescription must be individually progressed to continuously improve
cardiorespiratory

fitness

and

muscular

strength,

while

avoiding

health

complications.116 However, only one factor of FITT (frequency, intensity, time,
type) should be progressed at a time, and for aerobic training time or duration is
commonly increased first.116 A progressive exercise program is appropriate for
participants with severe CVDs and the elderly, as long as the participants have
been approved to engage in exercise.116 There are many factors to consider when
progressing a participant’s exercise prescription, especially the expectations and
preferences for personal goals that the participant possesses.116
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Regardless of a participant’s baseline level, the CACPR mentions that all
exercise prescriptions should commence with a 5 to 10-minute warm-up at an
intensity of 20% to 35% of the participant’s heart rate reserve (resting heart rate is
subtracted from heart rate max (HRmax)), and conclude with a cool-down of the
same length, but at 60% or less of the participant’s HRmax.22 Unlike the CACPR,
the AACVPR does not provide general recommendations for a warm-up and cooldown, but instead provides guidelines for specific populations such as those with
heart failure and cardiac transplantations.17
The CACPR alludes to including flexibility training in the exercise
prescription, but lacks a frequency and intensity, whereas the AACVPR suggests
two or three non-consecutive days per week at an intensity that is painless.17,22
However, the CACPR does suggest holding static stretches for 15 to 60 seconds
and completing more than four repetitions per exercise for each major muscle
tendon

group.22

Additionally,

partner

assisted

neuromuscular

facilitation

techniques are recommended by the CACPR and are to be performed by holding
a contraction for six seconds, shadowed by a 10 to 30 second assisted stretch.22
Similarly, the AACVPR recommends focusing on static stretches of the lower back
and thighs with a gradual increase in duration by holding each static stretch for 30
to 90 seconds, for 3 to 5 repetitions.17
1.3.1 Aerobic Training
In early outpatient CR, aerobic training is predominant with intensity being
the most impactful factor targeted for improvement.116 To determine aerobic
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training capabilities (i.e., cardiorespiratory fitness) a symptom-limited graded
exercise test is performed to establish a safe exercise prescription.17,22
The CACPR recommends aerobic training 3 to 5 days per week for 20 to
40 minutes per session at 40% to 85% of heart rate reserve.22 More recent
provincial guidelines from the CCN suggest partial recommendations for aerobic
training, stating it should be prescribed 5 to 7 days per week incorporating at least
30 minutes per session.91 Comparably, the AACVPR recommends aerobic training
most days of the week (i.e., 4 to 7 days per week) for 20 to 60 minutes per session,
at 40% to 80% of HRmax, metabolic reserve or maximal oxygen consumption.17
Aerobic exercise training may be accomplished on electronically designed
devices (e.g., treadmills or ergometers) or in locations that allow spacious activities
such as walking or cycling, either indoors or outdoors.17 Essentially, rhythmic
exercises that incorporate large muscle groups are recommended to sustain a
healthy body weight through an increase in caloric expenditure during these
activities.121
1.3.2 Resistance Exercise Training
The CACPR, AACVPR, and CCN recommend resistance training in
conjunction with aerobic training.17,22,91 To determine resistance training
capabilities, the gold standard is a one-repetition maximum (RM) test for each
resistance exercise that will be completed during the exercise program.116 The
CACPR and AACVPR both mention a 1RM test (maximal weight an individual can
lift once) to determine baseline musculoskeletal fitness, but the protocol should be
implemented conservatively and monitored (e.g., ECG, heart rate, blood pressure,
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and rating of perceived exertion (RPE)).17,22 Additionally, the multiple RM (6RM to
15RM; maximal weight an individual can lift 6 to 15 times) is also recommended
by the AACVPR as a less stressful protocol compared to the 1RM.17
The resistance training guidelines for CR recommend a frequency of 2 to 3
days per week (the AACVPR specifies non-consecutively) including 1 to 3 sets of
exercises encompassing both the upper and lower body.17,22 The importance of
breathing properly and not breath holding during resistance training is emphasized
in the guidelines.17,22 The CACPR suggests 12 to 15 repetitions of 6 to 10 different
exercises at a RPE of 11 to 15 (Borg 6 to 20 scale), and similarly, the AACVPR
suggests 10 to 15 repetitions of 8 to 10 different exercises at a RPE of 11 to 13
without severe fatigue.17,22 Additionally, the CACPR suggestions that intensity can
be quantified as 30% to 40% of a participant’s 1RM for upper body exercises, and
50% to 60% of the participant’s 1RM for lower body exercise.22 The CACPR and
AACVPR agree that resistance (i.e., weight) can be increased by approximately
5% once the participant can comfortably perform the prescribed repetitions (the
AACVPR specifies the upper limit of the repetition range).17,22 Many types of
exercises can be performed such as those utilizing resistance bands, free weights,
or weight machines.17
1.3.3 Exercise Monitoring
The degree of monitoring during exercise is determined based on preprogramming risk stratification and clinical judgement.17,22 ECG, heart rate, blood
pressure, and RPE (Borg Scale) are examples of variables monitored during
exercise in CR.17,22
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The level of ECG-monitoring or telemetry (e.g., continuous to intermittent)
that is required during exercise training can vary.17,22 For instance, in Canada it is
at the discretion of the medical director to determine the usage, type, and length
of telemetry monitoring, whereas in the United States, it may be mandatory for
insurance reimbursement.17,22
1.4 Performance and Quality Indicators
To ensure that involvement in CR remains safe for the participant, and to
ensure maximum outcome, the CACPR and AACVPR state that it is necessary to
evaluate performance measures periodically throughout program participation,
especially before enrollment and at program completion (i.e., graduation).17,22
The performance or quality of a CRP can be measured with evidence-based
indicators that ensure participants are receiving the best standard of care by the
CRPs implementing and following validated CR recommendations.95,97 More
specifically, the Canadian Cardiovascular Society (CCS) implements evidencebased performance measures or quality indicators to evaluate the efficiency of
CRPs in Canada.97 The CCS established 30 quality indicators, and determined the
“Top 5” quality indicators to be: three process indicators (percentage of eligible
inpatients referred, number of days between receipt of referral at the CRP to
enrollment, and percentage of enrolled individuals who received self-management
education), one outcome indicator (percentage of CR participants who achieved a
half metabolic equivalent increase in exercise capacity upon completion of the
program), and one structure indicator (percentage of CRPs with an emergency
response strategy).97
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Comparatively, the AHA and the ACC recently released updated
performance measures and quality measures to assist health professionals in the
United States with evaluating the performance or quality of CRPs.95 The AHA and
the ACC have subtypes of quality indicators comprising performance measures
and quality measures.95 Performance measures are based off of scientific
evidence and Class I clinical practice guidelines, therefore making performance
measures appropriate to publicly report and be used for payment for performance
programs.95 Although quality measures are important factors to evaluate, they do
not currently have the caliber of evidence to support the usage of quality measures
as performance measures.95
The AHA and the ACC have established six performance measures:
percentage of eligible referrals from an inpatient setting to CR, percentage of
eligible referrals from an outpatient setting to CR, percentage of eligible exercise
training referrals for heart failure from an inpatient setting, percentage of eligible
exercise training referrals for heart failure from an outpatient setting, and
percentage of CR enrollment both claims-based, and registry or electronic health
records based.95
When comparing the “Top 5” quality indicators from the CCS to the
performance measures proposed by the AHA and ACC, the only measure that
overlaps is the percentage of eligible referrals from an inpatient setting to CR.95,97
Evidently, governing bodies in Canada and the United States that provide national
guidelines for performance and quality measures may not equally value the same
measurements. The AHA and ACC seem to evaluate what would be considered
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process quality indicators by the CCS, focusing on rates of referral and
enrollment.95 While the CCS does evaluate process quality indicators related to
referral and enrollment rates, the CCS also evaluates other factors such as selfmanagement education deliverance, exercise capacity changes, and the
implementation of an emergency response strategy.97
Furthermore, when comparing the work from Grace and colleagues127, who
examined the Canadian Cardiac Rehab Registry (CCRR) (database for Canadian
CRPs intake and discharge data for participants) and the work by Pack and
colleagues128, who examined the AACVPR database (database for program
directors of verified AACVPR CRPs), differences are presented between the
countries for important quality indicators. For instance, Grace and colleagues127
estimated an average wait time of 84 days, which is much more than the wait time
of 3 to 4 weeks (21 to 28 days) for 49% of the CRPs that Pack and colleagues128
evaluated. In contrast, the results from the CCRR indicated a higher program
completion rate of 90%, compared to 75% for the AACVPR database.127,128 It is
important to note the slight variation in definition of program completion (CCRR:
some component of the CRP attended and a formal re-assessment conducted at
the end of participation; AACVPR: each program followed a unique definition for
program completion) between the two countries, but nevertheless comparing each
country’s strengths and weaknesses by examining performance measures or
quality indicators is important to determine how to improve CR utilization.127,128
This is significant considering CRPs in both Canada and the United States have
yet to create a standard of care where all quality indicators are being fulfilled to
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capacity (i.e., 100% quality), as demonstrated by Grace and colleagues and Pack
and colleagues.127,128
When quality indicators are monitored, and strategies are carried out to
increase quality indicator rates, promising improvements in CR utilization are
found. For example, a CRP at the Mayo Clinic (Rochester, Minnesota, United
States) progressively incorporated quality improvement projects and when
analyzing data from more than 1000 participants, the CRP’s participation rate was
successfully increased.129 More specifically, the CRP’s two-year quality
improvement project began by changing the program’s recommendation for
program duration to a full dose of 36 sessions for all participants in March 2010.129
Secondly, an informational video on CR, shown before hospital discharge and at
the first CR early outpatient session, was applied in November 2010.129 Finally, a
motivational program was incorporated into the early outpatient CR in July 2011,
where participants were rewarded for attending sessions and staff were rewarded
for high performance.129 Participants received a specific prize (e.g., parking pass,
T-shirt, tote bag) after every sixth session attended, and staff received similar
prizes for accomplishing tasks and promoting participant success.129 After the
implementation of this quality improvement project, attendance for this CRP
improved from 12 to 20 sessions per participant; in other words, there was a 40%
improvement in attendance rates over a short two-year time frame.129 Additionally,
the number of participants who completed 30 sessions increased from 14% to
39%, and the number of participants who completed all 36 sessions also increased
from 4% to 16%.129 These findings demonstrate how efficient a quality
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improvement project can be in increasing attendance and completion rates in a
short period of time, emphasizing that CRPs should continually strive to evaluate
and enhance program delivery.129
The study by Pack and colleagues129 emphasizes the importance of
frequently monitoring the performance and quality of CRPs to ensure that
alterations are being made to consistently improve program delivery, participation,
and the benefits that participants receive. The first step in achieving the best quality
of CR begins by ensuring programs are legitimately recording performance
measures or quality indicators, and from there improvement projects can be
carried out.
1.5 Summary of Background
CVD is currently the leading cause of death worldwide, but the majority of
CVD related mortality occurs from CAD, which accounted for over nine million
global deaths in 2016.1,2 Within Canada, CAD is a major cause of death, falling
second only to cancer, where approximately 1 in 12 (2.4 million) Canadians over
the age of 20 years lived with CAD in 2012-2013.5 Across a national border to the
United States, CAD is a predominant cause of death currently accounting for
43.8% of the lives lost to CVD.7
CR is a secondary prevention strategy delivered by a multidisciplinary team
of health professionals, with a focus on lifestyle interventions to manage the
modifiable risk factors associated with CVD and ultimately CAD.69 Exercise-based
CR has been shown to improve clinical outcomes and HRQoL for individuals with
CAD.68
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These benefits are delivered by utilizing the core components of CR to
improve an individual’s disease status.17,22 Consequently, outcome assessments
are necessary to ensure the efficacy of a CRP to deliver benefits to the
participant.17,22 The CCS, and the AHA in conjunction with the ACC, have formally
provided quality indicators for CRPs in Canada and the United States to be
evaluated, respectively.95,97 Despite the necessity of CR, CRPs in Canada and the
United States have yet to create a standard of care where all quality indicators
(e.g., CR enrollment and completion) are being fulfilled to capacity (i.e., 100%
quality).127,128
In fact, CR utilization and completion rates in both the Canada and the
United States remain suboptimal.96,103 Moreover, specific populations are less
likely to participate in CR (e.g., women, older individuals) and an array of other
barriers exist (e.g., transportation, financial constraints) that prevent individuals
from participating in and completing CR.107–114,128
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Chapter 2:
A Comparison of Cardiac Rehabilitation Services and Outcomes in the
Great Lakes Central Region
(Southwestern Ontario and Southeastern Michigan)
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2.1 Introduction
Cardiovascular disease (CVD) is currently the leading cause of death
worldwide, with the majority of CVD-related deaths occurring from coronary artery
disease (CAD), which accounted for over 9 million global deaths in 2016.1,2 Within
Canada, CAD is a major cause of death, second only to cancer, where
approximately 1 in 12 (2.4 million) Canadians over the age of 20 years lived with
CAD in 2012-2013.3 Across a national border to the United States, CAD is a
predominant cause of death currently accounting for 43.8% of the lives lost to
CVD.4
Cardiac rehabilitation (CR) is a secondary prevention strategy delivered by
a multidisciplinary team of health professionals, with a focus on lifestyle
interventions to manage the modifiable risk factors associated with CVD and
ultimately CAD.5 Exercise-based CR has been shown to improve clinical outcome
and health-related quality of life (HRQoL) in individuals with CAD.6
These benefits are delivered by utilizing the core components of CR to
improve a participant’s disease status.7,8 Consequently, outcome assessments are
necessary to ensure the efficacy of a cardiac rehabilitation program (CRP) to
deliver benefits to the participants.7,8 The Canadian Cardiovascular Society, and
the American Heart Association in conjunction with the American College of
Cardiology, have formally provided quality indicators for CRPs in Canada and the
United States to be evaluated, respectively.9,10 Despite the necessity of CR, CRPs
in Canada and the United States have yet to create an ideal standard of care where
all quality indicators (e.g., CR enrollment and completion) are being fulfilled to
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capacity (i.e., 100% quality).11,12 In fact, utilization and completion rates in both the
Canada and the United States are suboptimal.13,14 Moreover, specific populations
are less likely to participate in CR (e.g., women, older individuals) and an array of
other barriers exist (e.g., transportation, financial constraints) that prevent
individuals from participating in and completing CR. 14–23
2.2 Purposes and Hypotheses
CR improves clinical outcomes and HRQol in individuals with CAD. Despite
this CR is underutilized around the world, including in Canada and the United
States. Further, the degree of benefit in clinical subgroups and optimal duration
and program content are not clear. Thus, the ultimate goal is to create a CR model
(or models) that provide(s) the greatest level of care and outcomes for all
participants. As a first step in this process, the purpose of this study was to
compare models of care from four geographically close CR sites that span an
international border through examination of program characteristics and database
variables. Additionally, the participants were characterized and examined for
potential predictors of program completion at one site. It is hoped that this latter
work will lay a foundation for a larger-scale study spanning all four CR sites.
The following specific objectives were pursued in two phases:
Phase 1 - Objective 1: Describe the similarities and differences in program
characteristics (e.g., referral procedures, psychosocial services offered) between
and within Canadian-based (two sites) and United States-based (two sites) CRPs.
Objective 2: Determine common and unique database variables collected by the
four CR sites.
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Phase 2 - Objective 3: Determine factors that impacted graduation (i.e., program
completion) at one of the CR sites.
Hypothesis: It was hypothesized that the participants would be younger
individuals who were Caucasian (used interchangeably with White; African
American used interchangeably with Black) men with higher socioeconomic
status (i.e., higher education and employed), no comorbidities, and had
coronary artery bypass grafting (CABG) as an indication for referral.14–23 It
was further hypothesized that age, sex (used interchangeably with gender),
race, education, occupation status, comorbidities, and referral indication
would impact program completion.14–23
2.3 Clinical Significance
CAD is the leading cause of mortality worldwide.2 The weight of the
evidence suggests that CR reduces cardiovascular disease-related deaths and
hospitalizations, and improves HRQoL .6 Despite this, CR is underutilized around
the world, including in Canada and the United States. Furthermore, a standardized
model of care is not implemented internationally. Therefore, by comparing the
granular details of CR sites (e.g., program characteristics and database variables)
within and between countries in close geographical proximity, an ideal CR model
or models that increase rates of participation and program completion can be
fostered. Moreover, preliminary identification of participant characteristics and
associated barriers to program completion will frame the objectives for a broader
study with all four sites to maximize CR participation and completion.
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2.4 Methods
This study included four CR sites in the Great Lakes Central Region of North
America: two from Southwestern Ontario (Canada) and two from Southeastern
Michigan (United States). The University of Windsor (PACR Laboratory,
Department of Kinesiology, Faculty of Human Kinetics, Windsor, Ontario, Canada)
was deemed the central academic site. As described above in Section 2.2, this
study occurred in two phases. Phase 1 compared program characteristics and
database variables from all CR sites, while Phase 2 involved a single-site
retrospective database analysis. This study was cleared by all institutional
research ethics boards, which was captured under the master University of
Windsor’s Research Ethics Board (REB # 19-001/35602) clearance.
2.4.1 Phase 1
All four sites sent individual site program characteristics via secure email
and the program characteristics from each site were compiled into one master
Excel document housed at the University of Windsor. All four sites also sent
individual data dictionaries (either in WORD or Excel) via secure email, which were
compiled into one master Excel document housed at the University of Windsor.
2.4.2 Phase 2
De-identified data from thousands of historically consented participants who
attended an early outpatient CRP in Michigan (Michigan Site #2) between 2012 –
2016 were extracted from the site’s database and shared by secure file transfer
with the University of Windsor (PACR Laboratory, Department of Kinesiology,
Faculty of Human Kinetics). All non-essential identifying information was removed

77

by qualified CR research personnel at the site prior to transfer to the University of
Windsor (PACR Laboratory, Department of Kinesiology, Faculty of Human
Kinetics). Embedded in the de-identified data was no more than four HIPAA
identifiers. The HIPAA identifiers included in the database were: ZIP code, sex,
age, and race. To account for the inclusion of the HIPAA identifiers, a Data Sharing
Agreement was created to maintain participant confidentiality and anonymity.
2.5 Statistical Analysis
2.5.1 Phase 1
The information collected from the program characteristics and data
dictionaries did not require statistical analysis. These variables were compared
qualitatively to determine similarities and differences. A database variable was
considered to be common if at least two of the four sites (i.e., 50%) included it in
their data dictionaries, and a database variable was considered to be unique if only
one of the four sites included it in their data dictionary. Database variables were
examined according to the Canadian Association of Cardiovascular Prevention
and Rehabilitation (CACPR) and American Association of Cardiovascular and
Pulmonary Rehabilitation (AACVPR) guidelines, which recommend valuable
aspects to address and collect.7,8
2.5.2 Phase 2
The sample used for analyses was composed of first-time CR participants.
Following data cleaning procedures (identification of duplicate and anomaly
cases), descriptive statistics were conducted to characterize the population.
Participant characteristics (age, sex, race, education, occupation status,
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comorbidities, and referral indication) were assessed according to graduation
status (graduated or not graduated) using an independent-samples t-test and chisquared tests as appropriate to determine the factors that impacted program
completion from the early outpatient CRP in Michigan. Subsequent one-way
ANOVAs were conducted on occupation status and comorbidities to determine if
age was statistically different between the categories of these variables.
Univariate analyses were used to determine the predictor variables included
in the logistic regression. An independent-samples t-test demonstrated a
significant difference in age between participants who were graduated and not
graduated. Additionally, education, occupation status, and comorbidities were
found to have significant associations with graduation status according to chisquared tests and as such, age and these variables were included in the logistic
regression as predictor variables. As referral indication revealed no significant
association with graduation status and since it was comprised of several (10)
categories that could not be collapsed into smaller categories, it was not included
as a predictor variable. However, even though sex and race did not exhibit
significant associations with graduation status, these variables were included in
the analysis because of the potential for them to have joint predictive ability with
the other variables. Subsequently, an enter-method logistic regression with
graduation status (graduated or not graduated) as the outcome and participant
characteristics (age, sex, race, education, occupation status, and comorbidities)
as the predictor variables was conducted to further examine the factors that
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impacted program completion. Data are presented as mean ± standard deviation,
unless otherwise stated.
For the independent-samples t-test and one-way ANOVAs, outliers were
assessed by inspection of boxplots and z-scores, and normal distribution was
assessed by histograms, normal Q-Q plots, skewness, and kurtosis were
appropriate. Additionally, homogeneity of variance was assessed by Levene’s test
for equality of variance. For the chi-squared tests, all expected cell frequencies
were inspected to be greater than five for 2 by 2 contingency tables. For larger
tables, all expected cell frequencies were inspected to be greater than one and no
more than 20% were less than five. For the logistic regression, outliers were
assessed with standardized residuals and Cook’s Distance. Additionally, linearity
of the log odds transformation (logit) of the dependent variable with respect to the
continuous

independent

variable

(age)

(Box-Tidwell

procedure),

and

multicollinearity (tolerance values, VIF values, and correlation coefficients) were
assessed.
Statistical analyses were performed with IBM SPSS Statistics 25.0 (IBM
Corp, Armonk, New York) and statistical significance was p ≤ 0.05.
2.6 Results
2.6.1 Phase 1 – Objective 1: Program Characteristics Description
In brief, all CR sites were affiliated with a hospital and governed by their
respective health care systems, and most were affiliated with a university. The
Ontario sites had no program fee whereas the Michigan sites did. The Ontario sites
averaged two weekly onsite sessions with an average program duration of six
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months. Similarly, the Michigan sites averaged two to three weekly onsite
sessions, but the average range of program duration was typically less than the
Ontario sites. Please see Table 1 for details.
Table 1: Program Overview
Ontario Site #1
Yes

Ontario Site #2
Yes

Michigan Site #1
Yes

Michigan Site #2
Yes

Yes

Yes

No

Yes

Health Care
System

Health Care
System

Health Care
System

Health Care
System

Funding
Source

Ministry of Health/
Government

Ministry of Health/
Government

Commercial/
Government
Insurance

Commercial/
Government
Insurance

Program
Fee

No; Ministry of
Health /Provincial
health care
funding
2

No; Ministry of
Health /Provincial
health care
funding
2

Yes;
Copay/Deductible
as directed by
payor source
2-3

Yes;
Copay/Deductible
as directed by
payor source
2-3

6 months

6 months

8-18 weeks

12-18 weeks

Hospital
Affiliation
University
Affiliation
Governance

Average #
of Weekly
Onsite
Sessions
Average
Program
Duration

With respect to eligibility for referral there were many common diagnoses
accepted across the sites. An Ontario site accepted diagnoses that no other sites
accepted, as did the Michigan sites. Neither site in Ontario accepted “having (a)
CVD risk factor(s) only (e.g., hypertension but with no CVD event)”. Please see
Table 2 for details.
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Table 2: Eligibility for Referral
Diagnosis

Ontario Site #1

Ontario Site #2

Michigan Site
#1
Yes
Not specified

Michigan Site
#2
Yes
Not specified

Myocardial Infarction
Yes
Yes
Acute Coronary
Not specified
Yes
Syndrome
Stable Angina
Yes
Yes
Yes
Yes
Pectoris
PCI/Stent
Yes
Yes
Yes
Yes
CABG
Yes
Yes
Yes
Yes
Valve
Yes
Yes
Yes
Yes
Repair/Replacement
Congestive Heart
Yes
Yes
Yes
Not Specified
Failure
Systolic Heart Failure Not specified
Not specified
Not specified
Yes
LVAD
Not specified
Not specified
Yes
Not specified
Heart Transplant
Yes
Yes
Yes
Yes
Congenital Heart
Not specified
Yes
Not specified
Not specified
Disease
Other Cardiac
Not specified
Yes
Not specified
Not specified
Diagnoses†
Symptomatic PAD
Not specified
Not specified
Yes
Not specified
†
Cardiac arrhythmia, implantable cardioverter-defibrillator, pacemaker, cardiomyopathy
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; LVAD, left
ventricular assist device; PAD, peripheral arterial disease

Sites utilized a variety of automatic referral procedures, and there were
nuances between and within countries. Please see Table 3 for details.
Table 3: Referral Details
Ontario Site #1
Automatic referral
from acute care;
paper referrals
possible for
outpatient
settings

Ontario Site #2
Automatic referral
from acute care;
paper referrals
possible for
outpatient
settings

Require
Physician
Approval
Source

Yes

Rolling
Enrollment

Procedure

Michigan Site #2
Automatic; no
paper

Yes

Michigan Site #1
Automatic referral
for inpatients at
affiliated hospital
or outpatients at
affiliated
physician office;
paper referral for
participants
outside of
affiliated health
system
Yes

Inpatient/
Outpatient

Inpatient/
Outpatient

Inpatient/
Outpatient

Inpatient/
Outpatient

Yes

Yes

Yes

Yes
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Yes

All sites delivered the majority of core CR components to participants, but
one Michigan site did not offer pharmacotherapy management and the other
Michigan site did not offer tobacco cessation. None of the sites offered participation
incentives to participants. Please see Table 4 for details.
Table 4: Core Components
Exercise Training
Nutritional
Counselling
Psychosocial
Management
Pharmacotherapy
Management
Tobacco
Cessation
Other Risk Factor
Modification
Participation
Incentives

Ontario Site #1
Yes
Yes

Ontario Site #2
Yes
Yes

Michigan Site #1
Yes
Yes

Michigan Site #2
Yes
Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

No

No

No

No

All sites conducted an entry exercise test; however, one Michigan site did
not conduct this test on all participants. An Ontario site estimated maximal oxygen
consumption (VO2) whereas the other three sites measured maximal VO2. The
Michigan sites used telemetry during exercise sessions with slight nuances
between the two sites, while the Ontario sites did not use telemetry during exercise
sessions. Please see Table 5 for details.
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Table 5: Exercise Training Details
Entry Exercise Test

Measured Maximal
VO2
ECG Monitoring/
Telemetry

Ontario Site
#1
Yes

Ontario Site
#2
Yes

No;
estimated†
No

Yes

Michigan Site
#1
Yes; ~ 50% of
the time when
determined to be
necessary by CR
staff members
Yes

Michigan Site #2
Yes

Yes

No

Yes; first 3
Yes; transition to no
sessions then
monitoring if no
discontinued;
signs/symptoms and
restart if clinical
insurance approves
need
†
Measured maximal VO2 is when individuals perform exercise test protocols to determine maximal
VO2, whereas with estimated individuals do not reach maximal VO2, but instead reach submaximal
VO2 and maximal VO2 is estimated with equations
VO2, oxygen consumption; ECG, electrocardiogram

All sites collected data at intake and graduation. Three of the sites also
collected data during programming but there was variation in the quantity collected.
Only one site, located in Michigan, collected follow-up data. Please see Table 6
for details.
Table 6: Data Collection Time-Points
Intake
During
Programming

Graduation
Follow-up

Ontario Site #1
Yes
Yes; at 3
months;
laboratory
results, blood
pressure, and
anthropometric
measurements

Ontario Site #2
Yes
Yes; anytime
between intake
and exit when
warranted; allencompassing
similar to intake
assessment

Michigan Site #1
Yes
Yes; exercise test
when deemed
necessary

Michigan Site #2
Yes
No

Yes
No

Yes
No

Yes
No

Yes
Yes; at 1,6,12 months
after graduation and
every 6 months after
the year mark;
participant pays (not
covered by
insurance); allencompassing similar
to intake assessment
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All sites had a physician as the medical director. There was variation across
the sites in regard to the number of staff members for each occupation. However,
only one site in Ontario had a psychologist on staff. Please see Table 7 for details.
Table 7: Staff Members
Ontario Site #1
Physician

Ontario Site #2
Physician

Michigan Site #1
Physician

Michigan Site #2
Physician

Program
Director

Kinesiologist

Occupational
Therapist

Clinical Exercise
Physiologist

Exercise
Physiologist/Kine
siologist

Exercise
Physiologist/
Kinesiologist

6 on staff;
participant
interaction 2x
weekly

4 on staff;
participant
interaction 2x
weekly

15 on staff;
participant
interaction 2-3x
weekly

Dietitian

1 on staff;
participant
interaction varies;
1x biweekly, 1x
monthly, never;
determined by
intake
assessment
1 on staff;
participant
interaction varies;
biweekly, 1x
monthly, never
determined by
intake
assessment
0 on staff

2 on staff;
participant
interaction varies;
at intake for
everyone, 2-3
visits for other
participants

10 on staff;
participant
interaction 2-3x
weekly; supervise
exercise; conduct
50% of education
classes
1 on staff;
participant
interaction
through
conducting
remaining 50% of
education classes

1.5 on staff;
participant
interaction varies

0 on staff;
referred to as
needed by CR
staff members

1 on staff;
participant
interaction as
needed

1.5 on staff;
participant
interaction varies;
~8 visits for those
who referred by
CR staff
members
3 on staff;
participant
interaction varies;
intake and
graduation; could
occur for
progress if
warranted (e.g.,
medication
changes)

0 on staff;
referred to as
needed by CR
staff members

0 on staff;
referred to as
needed by CR
staff members

Medical Director

Social Work/
Behaviourist/
Stress
Management
Specialist

Psychologist

Nurse

2 on staff;
participant
interaction 1x
weekly

1 on staff;
0
1; participant
participant
interaction as
interaction at
needed
intake, 3 months,
6 months for
everyone; could
occur at other
points if
warranted (e.g.,
medication
changes)
The number of staff members are totals without specification of full-time or part-time positions
CR, cardiac rehabilitation
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Three of the sites offered home-based programming and the site that did
not was located in Michigan. For the sites that offered home-based programming,
there was variation across the sites regarding the details, with the largest
difference existing between the Ontario sites and the Michigan site. Please see
Table 8 for details.
Table 8: Home-Based Programming
Ontario Site #1

Ontario Site #2

Michigan Site #1

Available for All
Participants

Yes

Yes

Frequency of On-site
Sessions
Check-ins

Once monthly

Dependent on
self-efficacy for
exercise as
determined by CR
staff members
See below

Michigan
Site #2
No

Individualized

N/A

Individualized

N/A

Exercise Monitoring

Self-directed

May receive
phone, email, or
check-in visits by
CR staff members
Self-directed

N/A

Means of
Communication with
CR Staff Members
Program Fee

Phone and email

Core Component(s)
Deliverance of Other
Core Components

Exercise training
Participant attends
on-site CR
sessions

Heart rate monitor;
supervised by
clinician during
exercise training
Live two-way
audio and video
conference
Yes; same as onsite, but coverage
limited to 2
insurance
providers
Exercise training
Online slideshow
presentations/vide
os

No; only if
participant calls

No

Phone, email, and
automated text
message (piloted)
No

Exercise training
Participant attends
on-site CR
sessions; phone
follow-ups

CR, cardiac rehabilitation
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N/A
N/A

N/A
N/A

2.6.2 Phase 1 – Objective 2: Common and Unique Database Variables
Common Variables Collected at Intake
Referral and General Intake
There were no referral and general intake variables that were collected
across all four sites, however, the sites in Ontario collected the point of referral
(e.g., inpatient unit, emergency room, physician office) and date of the referral.
Medical History
All sites collected the event or indication for referral to early outpatient CR,
the diagnoses of hypertension and diabetes, and prescribed medications. Three
sites (two Ontario sites and a Michigan site) collected diagnoses of hyperlipidemia,
pulmonary or respiratory diseases (including sleep apnea), cerebrovascular
diseases, and bone and joint or musculoskeletal impairments or diseases. Two
sites (one Ontario and one Michigan) collected CVD information beyond that
collected to determine indication for referral to CR. The sites in Ontario collected
depression as an event or indication (i.e., diagnoses) for referral, primary CVD risk
factors, additional risk factors, medication relevant diagnoses, sensory
impairments, neurological diseases, and diagnosis of erectile dysfunction.
Physical Activity or Exercise Patterns
There were no variables that were collected across all four sites. Three sites
(two Ontario sites and a Michigan site) collected musculoskeletal limitations to
exercise. The Ontario sites also collected other non-cardiac limitations to exercise
(e.g., neurological, sensory). The sites in Michigan collected exercise frequency.
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Alcohol Consumption
There were no variables that were collected across all four sites. Three sites
(two Ontario sites and a Michigan site) collected the current status of the
participant drinking alcohol, the amount, and various questions related to the
excessive use of alcohol.
Tobacco Use
All sites collected the current status of the participant smoking tobacco.
Three sites (two Ontario sites and a Michigan site) collected the amount smoked
per day and the smoking tobacco quit date, if applicable. The sites in Ontario
collected the frequency of smoking tobacco and the number of years smoking
tobacco.
Demographic Information
All sites collected a variation of demographic variables at intake. More
specifically, all sites collected address, date of birth or age, sex or gender, and
race or ethnic group. Three sites (two Ontario sites and a Michigan site) collected
marital status, living situation (e.g., alone, with spouse, with children), education,
occupation, and current occupation status (e.g., active, unemployed, retired). The
sites in Ontario also collected desired occupation status, spoken language, and
type of residence (e.g., home, apartment, acute care hospital).
Travel Time
There were no variables that were collected across all four sites, however
the sites in Ontario collected the travel time for participants to attend CR.
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Physical Evaluation
All sites collected blood pressure, weight, height, and a variation of
dysrhythmia history. Three sites (two Ontario sites and a Michigan site) collected
ejection fraction and laboratory results including a lipid profile, and glucose and
glycosylated hemoglobin (HbA1c) measurements. The sites in Ontario collected
resting ankle blood pressure, resting heart rate, other blood components, the
Canadian Cardiovascular Society angina grade, and the New York Heart
Association heart failure class.
Exercise Test
All sites collected the exercise test protocol used, the exercise test duration,
peak blood pressure (systolic and diastolic), heart rate during the exercise test,
and measured functional capacity by collecting maximal VO2 or peak oxygen
uptake (ml/kg/min) (estimated or measured). Additionally, all sites collected some
variation of signs and symptoms that occurred during the exercise test, including
electrocardiogram (ECG) changes with a focus on ischemia/ST changes and
evidence of angina. Three sites (two Ontario sites and a Michigan site) collected
rating of perceived exertion (utilizing a variation of the Borg Scale) during the
exercise test and the reason that the exercise test was terminated. The sites in
Ontario collected the exercise test location (on-site, off-site, elsewhere), resting
blood pressure (systolic and diastolic) and heart rate before the exercise test, and
lung function (e.g., normal, mild, obstructive disease).
It should be noted that some of the variables collected with exercise tests,
which can occur at different time-points and not for every participant, could be

89

relevant to the Medical History and Physical Evaluation as well. As such, the
variables have been included in these headings. Nonetheless, consideration
needs to be made regarding the fact that if an exercise test is not conducted, this
information may not be collected or may be collected in a format not captured by
the current data dictionary.
Questionnaires
Overall Health Related Questionnaires
There were no common questionnaires collected.
Psychological Health Related Questionnaires
There were no psychological health related questionnaires that were
collected across all four sites. The sites in Ontario collected the Hospital Anxiety
and Depression Scale (HADS).
Physical Health Related Questionnaires
There were no common questionnaires collected.
Nutrition Related Questionnaires
There were no common questionnaires collected.
Staff Members
There were no variables that were collected across all four sites, but three
sites (two Ontario sites and a Michigan site) collected the case manager. The sites
in Ontario collected if a nurse practitioner was required and the type of care (e.g.,
regular, heart failure, chronic obstructive pulmonary disease [COPD]).

90

Unique Variables Collected at Intake
For a summary of the unique variables collected at intake please see Table
9 below.
Table 9: Unique Variables Collected at Intake
Ontario
Site #1
Referral and General Intake
First early outpatient CR visit that is
billable
Previous CR participation
Medical History
Background events impairing
cardiovascular health
Allergies
Signs and symptoms of cardiac
conditions
General fatigue
Cancer
Gastrointestinal
Genitourinary
Neuropsychiatric (e.g., depression,
anxiety)
Hematology
Pregnancy history
Gynecological history
Family history
Body weight history and eating
habits†
Physical Activity or Exercise Patterns
Type of exercise performed (cardio
or strength training)
Amount for each type of exercise
Accessibility to exercise equipment
at home
Membership to a gym
Alcohol Consumption
Motivation to quit drinking alcohol
(0-10 scale)
Tobacco Use
Number of quitting attempts
Acceptance of inpatient or
outpatient smoking cessation
services
Type of tobacco smoked
(cigarettes, cigars, pipe, smokeless
tobacco)
Amount each type of tobacco is
used
Quit date for each type of tobacco
Motivation to quit smoking (0-10
scale)

Ontario
Site #2

Michigan
Site #1

Michigan
Site #2

a
a
a
a
a
a
a
a
a
a
a
a
a
a
a

a
a
a
a
a
a
a
a
a
a
a
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-

Status of a participant living with
someone who smokes
Demographic Information
Insurance information
Religion
Rating of one’s marriage (e.g.,
excellent, poor)
Number of children
Social support (i.e., the main
source and the rating for the
amount received)
Physical Evaluation
Framingham risk score
a
Fall related questions
Body composition
Criteria for metabolic syndrome
Electrocardiogram evidence of left
ventricular hypertrophy
Myocardial infarction or cardiac
surgery complicated by cardiogenic
shock
Coronary angiography and
obstruction details
Lower and upper heart range
Indication for use of rating of
perceived exertion only
Exercise Test
Reason for the exercise test (i.e.,
for early outpatient cardiac
rehabilitation or not)
Supine blood pressure (systolic and
diastolic) and heart rate
Standing blood pressure (systolic
and diastolic) and heart rate
Test type in regard to estimated or
measured functional capacity
6-minute hall walk results
Specific signs and symptoms
included arrhythmia information
and systolic blood pressure
response (e.g., hypo, blunted)
Questionnaires
Overall Health Related Questionnaires
Short Form (12) Health Survey (SF12)
Short Form (36) Health Survey
Version 2.0 (SF-36 V2)
Dartmouth COOP Health Survey
Psychological Health Related Questionnaires
Patient Health Questionnaire
(PHQ-9)
Brief Symptom Inventory (BSI-53)
Physical Health Related Questionnaires
Duke Activity Status Index (DASI)
Human Activity Profile (HAP)
Nutrition Related Questionnaires
Rate Your Plate
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a
a
a
a
a
a

a
a
a
a
a
a
a
a

a
a
a
a
a
a

a
a
a
a
a
a
a
a

-

Customized Food Frequency
a
Survey/Assessment
†
Database variables included: a healthy weight the participant considered for themselves, previous or
current weight-loss programs, previous dietician counselling, motivation, confidence and obstacles to
implementing improvements in diet

Common Variables Collected During Programming
Attendance
There were no variables that were collected across all four sites. The sites
in Ontario collected attendance rates for specific core components including:
attendance for cardiac education (independent and group), diabetes education,
dietary counselling (independent), dietary education (group), exercise counselling
(independent), exercise education (group), medication counselling (independent
and group), psychosocial education (group), stress management (group),
supervised exercise, home-based exercise, smoking cessation, psychology
services, social work services, women’s support group, vocational assessment
and counselling, and pharmacotherapeutic sessions. The sites in Michigan
collected the total number of early outpatient CR sessions attended.
Unique Variables Collected During Programming
For a summary of the unique variables collected during programming
please see Table 10 below.
Table 10: Unique Variables Collected During Programming
Ontario
Site #1
Attendance
Exercise training days per
week
Total electrocardiogram
monitored sessions
Number of sessions approved
Number of sessions prescribed
Number of sessions per week

Ontario
Site #2

Michigan
Site #1

Michigan
Site #2

a
a
a
a
a
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Common Variables Collected at Graduation
Medical History
There were no variables that were collected across all four sites. Three sites
(two Michigan sites and an Ontario site) collected prescribed medications. Three
different sites (two Ontario sites and a Michigan site) collected the presence of
hypertension. The Ontario sites collected if participants were sedentary, had high
blood cholesterol, or psychological concerns at graduation, and if the participants
were going to attend pulmonary rehabilitation.
Physical Activity or Exercise Patterns
There were no variables that were collected across all four sites. The sites
in Michigan collected exercise frequency.
Alcohol Consumption
There were no variables that were collected across all four sites. An Ontario
site and a Michigan site collected the current status of the participant drinking
alcohol, the amount, and various questions related to the excessive use of alcohol.
Tobacco History
There were no variables that were collected across all four sites. Three sites
(two Michigan sites and an Ontario site) collected the current status of the
participant smoking tobacco. An Ontario and a Michigan site collected the amount
smoked per day.
Demographic Information
There were no variables that were collected across all four sites. The
Ontario sites collected occupation status (e.g., active, unemployed, retired).
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Physical Evaluation
All sites collected resting blood pressure. Three sites (two Michigan sites
and an Ontario site) collected weight. An Ontario and Michigan site collected
laboratory results including a lipid profile, glucose, and glycosylated hemoglobin
(HbA1c) measurements, and resting heart rate.
Exercise Test
All sites conducted an exercise test at graduation and collected relative
variables. Please refer to Exercise Test under Variables Collected at Intake for
more detail.
It should be noted that some of the variables collected with exercise tests,
which can occur at different time-points and not for every participant, could be
relevant the Medical History and Physical Evaluation as well. As such, the
variables have been included in these headings. Nonetheless, consideration
needs to be made regarding the fact that if an exercise test is not conducted, this
information may not be collected or may be collected in a format not captured by
the current data dictionary.
Questionnaires
Overall Health Related Questionnaires
There were no common questionnaires collected.
Psychological Health Related Questionnaires
There were no common questionnaires collected.
Physical Health Related Questionnaires
There were no common questionnaires collected.
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Nutrition Related Questionnaires
There were no common questionnaires collected.
Program Evaluation Questionnaire
There were no common questionnaires collected.
Reason for Graduation
There were no variables that were collected across all four sites. Three sites
(two Ontario sites and a Michigan site) collected the reason a participant graduated
or ceased to attend CR (e.g., completed program, insurance, return to work).
Unique Variables Collected at Graduation
For a summary of the unique variables collected at graduation (i.e., program
completion) please see Table 11 below.
Table 11: Unique Variables Collected at Graduation
Ontario
Site #1
Medical History
Lower limb claudication
Pulmonary or respiratory diseases
Cerebrovascular diseases
Bone and joint or musculoskeletal
impairments or diseases
Sensory impairments
Neurological diseases
Erectile dysfunction
Allergies
Signs and symptoms of cardiac
conditions
Cardiac events or tests since the
participant’s previous evaluation
Gynecological history
Diabetes
Physical Activity or Exercise Patterns
If strength training was being performed
Accessibility to exercise equipment at
home
Membership to a gym
Participant’s exercise plan following
graduation
Alcohol Consumption
Motivation to quit drinking alcohol (0-10
scale)
Tobacco Use

Ontario
Site #2

Michigan
Site #1

Michigan
Site #2

a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a

a
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-

Frequency of smoking tobacco
Number of years smoking tobacco
Number of quitting attempts
Smoking tobacco quit date
Type of tobacco smoked (cigarettes,
cigars, pipe, smokeless tobacco)
Amount each type of tobacco is used
Motivation to quit smoking (0-10 scale)
Obstacles to quitting
Tobacco products quit in the last 6
months
Status of a participant living with
someone who smokes
Physical Evaluation
Resting ankle blood pressure
Resting heart rate
Blood components beyond lipid profile,
glucose, and glycosylated hemoglobin
(HbA1c)
Canadian Cardiovascular Society
angina grade
New York Heart Association heart
failure class
Ejection fraction
Dysrhythmia history
Body composition
Questionnaires
Overall Health Related Questionnaires
Short Form (12) Health Survey (SF-12)
Short Form (36) Health Survey Version
2.0 (SF-36 V2)
Dartmouth COOP Health Survey
Psychological Health Related Questionnaires
Hospital Anxiety and Depression Scale
(HADS)
Patient Health Questionnaire (PHQ-9)
Brief Symptom Inventory (BSI-53)
Physical Health Related Questionnaires
Duke Activity Status Index (DASI)
Human Activity Profile (HAP)
Nutrition Related Questionnaires
Rate Your Plate
Customized Food Frequency
Survey/Assessment
Program Evaluation Questionnaire
Customized Patient Satisfaction Survey
Behaviour Modification/Program Compliance Problems
Taking medications
Getting regular exercise
Quitting smoking
Eating correctly
Controlling body weight
Drinking alcohol in moderation or not at
all
Coping with stress
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a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a

a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a

2.6.3 Phase 2 – Objective 3: Michigan Site Data Analysis
Data cleaning identified no duplicate cases, but one anomaly case was
removed from the sample producing the final sample size of 1265 CR participants.
Characterization of Population
Participants were predominately Caucasian (n = 1044), men (n = 896),
university educated (n = 633), and not actively employed (n = 634). More than one
half of the population had two or more comorbidities (n = 749). The three most
common referral indications were percutaneous coronary intervention (PCI)/Stent
(n = 312), myocardial infarction (MI) (n = 272), and valve replacement/repair (n =
207). Please see Table 12 for details.
Table 12: Participant Characteristics
Total Sample
(N = 1265)
62.51 ± 11.81

Age (years; mean ± SD)
Sex (n; % of total sample)
Women
Men

369 (29.2%)
896 (70.8%)

Caucasian

1044 (82.5%)

African American

86 (6.8%)

Other

135 (10.7%)

University

633 (50.1%)

College/Post-Secondary

378 (29.9%)

High School or Less

187 (14.8%)

Unknown

65 (5.1%)

Active

574 (45.4%)

Retired

510 (40.3%)

Unemployed

40 (3.2%)

Medically Disabled

84 (6.6%)

Unknown

57 (4.5%)

Race (n; % of total sample)

†

Education (n; % of total sample)

Occupation Status (n; % of total sample)

‡

Comorbidities (n; % of total sample)
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No Comorbidity

221 (17.6%)

1 Comorbidity

287 (22.8%)

2 Comorbidities

350 (27.8%)

>2 Comorbidities

399 (31.7%)

Referral Indication (n; % of total sample)
PCI/Stent

312 (24.7%)

MI

272 (21.5%)

Valve Replacement/Repair

207 (16.4%)

CABG

185 (14.6%)

MI/PCI

157 (12.4%)

Heart Failure

50 (4.0%)

CABG/Valve Replacement/Repair

28 (2.2%)

Stable Angina

26 (2.1%)

Heart Transplant

5 (0.4%)

Other

23 (1.8%)

†

Education had 2 (0.2%) system missing cases
Comorbidities had 8 (0.6%) system missing cases
SD, standard deviation; PCI, percutaneous coronary intervention; MI, myocardial infarction; CABG,
coronary artery bypass grafting
‡

Participant Factors and Program Completion
Program completion or graduation for a participant was classified as the
participant attending at least 75% of the CR sessions that were prescribed to the
participant. The number of prescribed sessions varied according to the number of
sessions approved by insurance, which is typically 36 sessions. Most participants
in the current sample (64.4%) were prescribed 36 sessions. Graduation status
(graduated or not graduated) was not recorded for two participants from the
original sample (N = 1265), consequently the final sample size was 1263
participants. There were 321 (25.4%) non-graduates and 942 (74.6%) graduates.
Participant factors and graduation status are reported below and summarized in
Table 13.
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Comparison of Graduation Status and Age
An independent-samples t-test revealed a significant difference in age
between non-graduates and graduates. Non-graduates (60.47 years ± 12.44) were
significantly younger than graduates (63.21 years ± 11.52) [difference = -2.74
years (95% confidence interval [CI], -4.23 to -1.24); t(1261) = -3.599, p < 0.0005].
Comparison of Graduation Status and Sex
A chi-squared test revealed no significant association between graduation
status and sex (men or women), χ2(1) = 0.004, p = 1.00.
Comparison of Graduation Status and Race
A chi-squared test revealed no significant association between graduation
status and race (Caucasian, African American, and other [Asian, Hispanic, Middle
Eastern, Native American, South East Asian, other, unknown]), χ2(2) = 0.087, p =
0.958.
Comparison of Graduation Status and Education
A chi-squared test revealed a significant association between graduation
status and education (university [bachelor’s degree, some post graduate, master’s
degree, PhD, and medical doctor], college/post-secondary [some college, trade
school, and associate’s degree], high school or less [some high school and high
school/GED], and unknown), χ2(3) = 35.887, p < 0.0005. The proportion of
graduates (54.9%) with university education was significantly more than those that
did not graduate (36.3%). The proportion of graduates with college/post-secondary
education (27.4%) or high school or less education (12.6%) was significantly less
than the proportion that did not graduate (36.9% and 21.3%, respectively).
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Comparison of Graduation Status and Occupation Status
A chi-squared test revealed a significant association between graduation
status and occupation status (active, retired, unemployed, medically disabled, and
unknown), χ2(4) = 22.786, p < 0.0005. The proportion of graduates (42.6%) that
were retired was significantly more than the proportion that did not graduate
(33.6%). The proportion of graduates that were medically disabled (4.9%) was
significantly less than the proportion that did not graduate (11.5%).
Comparison of Graduation Status and Comorbidities
A chi-squared test revealed a significant association between graduation
status and number of comorbidities (none, one, two, and greater than two), χ2(3)
= 8.607, p = 0.035. The comorbidities included any type of cancer, hypertension,
high blood cholesterol, bronchitis (as a measure of COPD), emphysema (as a
measure of COPD), stroke, diabetes, kidney disease, and depression. The
proportion of graduates that had more than two comorbidities (29.7%) was
significantly less than the proportion that did not graduate (38.1%).
Comparison of Graduation Status and Referral Indication
A chi-squared test revealed no significant association between graduation
status

and

referral

indication

(MI,

PCI/stent,

MI/PCI,

CABG,

valve

replacement/repair, CABG/valve replacement/repair, heart transplant, stable
angina, heart failure, other), χ2(9) = 6.865, p = 0.651.
Table 13: Participant Factors and Graduation Status
Graduation Status (N = 1263)
Graduated
(n = 942)
Age (years; mean ± SD)

63.21 ± 11.52
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Not
Graduated
(n = 321)
60.47 ± 12.44

P Value
< 0.0005*

Sex (n; % within graduation status)

1.00
Women

274 (29.1%)

94 (29.3%)

Men

668 (70.9%)

227 (70.7%)

Race (n; % within graduation status)

0.958
Caucasian

African American
Other

778 (82.6%)

264 (82.2%)

63 (6.7%)

23 (7.2%)

101 (10.7%)

34 (10.6%)

‡

Education (n; % within graduation status)

< 0.0005*
†

517 (54.9%)

116 (36.3%)

†

258 (27.4%)

118 (36.9%)

†

119 (12.6%)

68 (21.3%)

47 (5.0%)

18 (5.6%)

University
College/Post-Secondary

High School or Less

Unknown
Occupation Status (n; % within graduation
status)

< 0.0005*
Active

428 (45.4%)

146 (45.5%)

†

401 (42.6%)

108 (33.6%)

Unemployed

29 (3.1%)

11 (3.4%)

Medically Disabled†

46 (4.9%)

37 (11.5%)

Unknown

38 (4.0%)

19 (5.9%)

Retired

§

Comorbidities (n; % within graduation status)

0.035*

No Comorbidity

172 (18.4%)

49 (15.4%)

1 Comorbidity

225 (24.0%)

62 (19.5%)

2 Comorbidities

262 (28.0%)

86 (27.0%)

†

278 (29.7%)

121 (38.1%)

>2 Comorbidities

Referral Indication (n; % within graduation
status)
PCI/Stent

222 (23.6%)

89 (27.7%)

MI

201 (21.3%)

70 (21.8%)

Valve Replacement/Repair

157 (16.7%)

50 (15.6%)

CABG

147 (15.6%)

38 (11.8%)

MI/PCI

122 (13.0%)

35 (10.9%)

Heart Failure

36 (3.8%)

14 (4.4%)

CABG/Valve Replacement/Repair

20 (2.1%)

8 (2.5%)

Stable Angina

18 (1.9%)

8 (2.5%)

4 (0.4%)

1 (0.3%)

15 (1.6%)

8 (2.5%)

Heart Transplant
Other

0.651

*p ≤ 0.05
†
Significantly different column proportions
‡
Education had 2 system missing cases; therefore, n = 1261 for relative analysis
§
Comorbidities had 8 system missing cases; therefore, n = 1255 for relative analysis
SD, standard deviation; PCI, percutaneous coronary intervention; MI, myocardial infarction; CABG,
coronary artery bypass grafting
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Comparison of Age and Occupation Status
Since age was significantly different between graduates and nongraduates, and occupation status had a significant association with graduation
status (discussed above), a one-way ANOVA was conducted to determine if age
differed based on occupation status. There were no identified system missing
cases (N = 1265). Homogeneity of variances was violated as assessed by
Levene's test for equality of variance (p = 0.002). Therefore, a Welch ANOVA was
conducted and revealed that age was significantly different between different
occupation status, Welch's F(4, 153.978) = 195.932, p < 0.0005. Participants were
categorized into five groups: active (n = 574; 56.65 years ± 10.18), retired (n = 510;
71.01 years ± 8.37), unemployed (n = 40; 56.55 years ± 7.75), medically disabled
(n = 84; 53.77 years ± 9.36), and unknown (n = 57; 62.46 years ± 11.35). GamesHowell post hoc analysis revealed that the differences in age between retired
participants and that who were unknown (-8.56 years, 95% CI -12.903 to -4.208),
active (-14.36 years, 95% CI -15.902 to -12.821), unemployed (-14.46 years, 95%
CI -18.093 to -10.831), or medically disabled (-17.24 years, 95% CI -20.253 to 14.223) were all statistically significant (p < 0.0005), with retired individuals being
the oldest participants.
Comparison of Age and Prevalence of Comorbidities
Since age was significantly different between graduates and nongraduates, and the prevalence of comorbidities had a significant association with
graduation status (discussed above), a one-way ANOVA was conducted to
determine if age differed based on comorbidity prevalence. There were eight
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identified system missing cases for comorbidities (N = 1257). A one-way ANOVA
revealed that age was statistically significantly different between the groups with
different frequencies of comorbidities, F(3,1253) = 8.657, p < 0.0005. Participants
were categorized into four groups: greater than two comorbidities (n = 399; 64.28
years ± 10.76), two comorbidities (n = 350; 63 years ± 11.65), one comorbidity (n
= 287; 61.83 years ± 12.52) and no comorbidity (n = 221; 59.43 years ± 12.32).
Tukey post hoc analysis revealed that the increase in age between greater than
two comorbidities and no comorbidity groups (4.85 years, 95% CI 2.321 to 7.371)
was statistically significant (p < 0.0005), indicating that participants with greater
than two comorbidities were older. Similarly, the increase in age between greater
than two comorbidities and one comorbidity groups (2.45 years, 95% CI 0.116 to
4.777) was statistically significant (p = 0.035), indicating that participants with
greater than two comorbidities were older. Additionally, the increase between two
comorbidities and no comorbidity groups (3.57 years, 95% CI 0.983 to 6.157) was
statistically significant (p = 0.002), indicating that participants with two
comorbidities were older.
Logistic Regression Model for Graduation Status
There were 12 identified system missing cases among all included
variables; therefore, N = 1253. A logistic regression was performed to determine
the likelihood that participants graduated or did not graduate from the program with
age, sex, race, education, occupation status, and comorbidities as predictors in
the model. A test of the final model, including all six predictors, compared to the
constant only model was statistically significant χ2(14) = 63.022, p < 0.0005,
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Nagelkerke R2 = 0.072. The model correctly classified 75.1% of cases. Age was
significantly associated with graduation status, where a one unit (one year)
increase in age was associated with a 1.6% increase in the likelihood of graduating
(odds ratio [OR] 1.016, 95% CI 1.002 to 1.030, p = 0.027). Education was
significantly associated with graduation status, were compared to university
education, high school or less education (OR 0.435, 95% CI 0.297 to 0.637, p <
0.0005) and college/post-secondary education (OR 0.518, 95% CI 0.380 to 0.707,
p < 0.0005) decreased the likelihood of graduating by 56.5% and 48.2%,
respectively. The predictor comorbidities were trending towards significance (p =
0.067). The results for the logistic regression are presented in Table 14.
Table 14: Predictors of Program Completion
Predictor

Odds Ratio (95% CI)

P Value

Age (years)

1.016 (1.002-1.030)

0.027*

Sex (ref: men)

1.136 (0.847-1.525)

0.395

Race (ref: Caucasian)

0.579
African American

1.319 (0.779-2.234)

0.303

Other

0.982 (0.640-1.508)

0.935

Education (ref: university)

< 0.0005*
High School or Less

0.435 (0.297-0.637)

< 0.0005*

College/Post-Secondary

0.518 (0.380-0.707)

< 0.0005*

Unknown

0.640 (0.335-1.222)

0.176

Occupation Status (ref: active)

0.106
Retired

1.181 (0.823-1.693)

0.366

Unemployed

1.211 (0.575-2.553)

0.614

Medically Disabled

0.583 (0.351-0.969)

0.037

Unknown

0.739 (0.384-1.419)

0.363

Comorbidities (ref: >2 comorbidities)

0.067

No Comorbidity

1.502 (1.002-2.253)

0.049

1 Comorbidity

1.553 (1.076-2.241)

0.019

2 Comorbidity

1.332 (0.951-1.866)

0.095

*p ≤ 0.05
CI, confidence interval; ref, reference group
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2.7 Discussion
CAD is the leading cause of mortality worldwide.2 CR is a secondary
prevention program known to improve clinical outcomes and HRQoL in patients
with CAD.6 Despite this, CR is underutilized around the world, and a CR model or
models that is/are most efficient for all cohorts of participants in varying locations
has yet to be established.13,14 The global CR “process” from referral to program
completion is fairly similar, yet the “granular” details are less uniform: program
characteristics, database dictionaries (e.g., what information is collected from
participants and when), and participant characteristics vary, additionally different
participant-level and system-level barriers exist. Consequently, not all standard-ofcare quality indicators are being met. To provide the greatest level of care, achieve
the best possible outcome, and lower participant- and system-level barriers, it is
essential to create an ideal CR model (or models) that encourage attendance and
completion while meeting all standard of care quality indicators. This study took an
important first step toward creating such a model (or models). Key findings
emerging from this study are summarized in Table 15. These important findings
are discussed in more detail below.
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Table 15: Key Findings
Objective 1: Program Characteristics Description
•

All sites may want to consider “pre-habilitation” programs for individuals who have not yet
had a CVD event, but have CVD risk factors

•

All sites may want to implement cost-effective participation incentives

•

Michigan sites may want to consider adopting the “use as needed” format for telemetry;
similar to Ontario sites

•

All sites may want to consider collecting more participant data during programming
Objective 2: Common and Unique Database Variables

•

All sites may want to collect point and date of referral

•

All sites may want to collect previous participation in CR

•

All sites may want to collect signs and symptoms of a participant’s cardiac condition(s) and
a detailed history of comorbidities

•

All sites may want to collect more informative data regarding dietary content and eating
habits

•

All sites may want to collect the availability of exercise equipment at home and a gym
membership

•

All sites may want to collect religion

•

All sites may want to collect the spoken language of participants

•

All sites may want to collect a participant’s desired occupation status

•

All sites may want to collect travel distance to CR

•

All sites may want to collect risk of falling questions

•

All sites may want to collect attendance for each core component

•

All sites may want to collect adherence issues for core components at graduation
Objective 3: Michigan Site Data Analysis

•

Participants were predominantly Caucasian men with university education

•

Participants predominantly had more comorbidities and were not actively employed

•

Having less than university education decreased the likelihood of graduating

•

Increasing age modestly increased the likelihood of graduating
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2.7.1 Phase 1 – Program Characteristics and Database Variables
In both Canadian and United States-based CR models, the following steps
occur: 1) an individual with an eligible diagnosis or diagnoses is referred to early
outpatient CR, 2) individuals are contacted by a CRP liaison to arrange an intake
appointment and undergo an intake assessment of key variables relative to a
medical history, demographic information and other influences on health that may
pose as barriers to CR participation and completion, a physical evaluation, and an
exercise stress test protocol (all variables are collected in a database guided by
the database dictionary), 3) the individual then begins an individualized early
outpatient CRP, 4) individuals graduate from the early outpatient CRP and at
program completion are re-evaluated on key variables (and occasionally at other
time-points during the program), 5) after completion (i.e., graduation) of the early
outpatient CRP an individual may begin the maintenance phase, 6) in some early
outpatient CRPs individuals are evaluated again during long-term follow up (either
as part of or separate to a structured maintenance phase; also reflected in the
database dictionary).
The examination of the program characteristics and database variables for
the four CR sites provided valuable insight into the granular details of all the
previously mentioned steps. Moreover, the inclusion of two Ontario sites and two
Michigan sites promoted within and between country comparisons of CR models.
Objective 1: Program Characteristics Description
As expected, similarities and differences were discovered between the
Canadian-based and United States-based sites. This held true when comparing

108

sites from the same country, yet similarities were most prevalent when sites were
located in the same country.
Program Overview
All CRPs operated under the auspice of a health care system and were
accordingly affiliated with a hospital. The sites in Ontario received funding from the
Ministry of Health (i.e., the Government) and participants did not have a program
fee as this was covered by provincial health care funding. In Michigan, the
programs received commercial or government insurance funding, and program
fees and participant co-payments were dependent on the funding source.
Recognizing that financial cost is a barrier to program participation and
completion, exploring ways to reduce participant-level cost is important,
particularly in the United States.13–15,23 The Million Hearts Cardiac Rehabilitation
Collaborative in the United States (founded by the Centres for Medicare and
Medicaid Services and the Centres for Disease Control and Prevention) is
composed of a spectrum of individuals involved with CR deliverance (e.g., federal
and private sector organizations, CR participants) with the common goal of
preventing one million cardiovascular events within five years.13 This collaborative
suggests that to reduce expenses for CR participants, negotiations with insurance
companies could occur to minimize out-of-pocket participant expenses, and a
charitable fund supported by previous graduates or other donors could be
established to provide financial assistance to participants with high-copayments or
no insurance.13,24–26 The complexity of devising plans to share health care costs is
widely acknowledged as solutions are constrained by policies and procedures
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within the health care system.24,25 Investigation into smaller scale strategies to
reduce financial barriers for participants is warranted.
As part of the program overview, the Ontario sites indicated that the average
number of weekly onsite sessions was two with an overall program duration of six
months, directly aligning with national guidelines.8 In the United States, program
duration is typically examined in accordance with the number of sessions approved
by insurance usually equating to 36 onsite sessions, and commonly occurring
three times per week.7 The Michigan sites offered 2 to 3 weekly onsite sessions
that spanned anywhere from 8 to 18 weeks, with the actual program duration
typically correlated with the number of insurance approved sessions. Evidently,
overall program duration was longer within the Ontario sites suggesting that the
Michigan sites could make between country comparisons to determine the number
of weekly onsite sessions and overall program length that produces the most
favorable outcomes for participants. In the United States, the ideal prescription for
insurance to cover would presumably be the minimal amount of sessions needed
to achieve benefit, however, this reduction in program duration may appeal to
participants (e.g., minimization of financial burden and time-commitment) as well.
Eligibility for Referral
In general, the findings of this study provided support for similar referral
eligibility criteria on either side of the border.7,8,10,27 All sites accepted referrals for
an array of diagnoses that aligned with mandated eligibility criteria put forth by the
CR governing bodies in both Canada and the United States.7,8,10,27 However, one
of the sites (located in Ontario) explicitly stated referral acceptance for acute
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coronary syndrome (ACS) and not solely MI, despite ACS being eligible in both
countries.7,8,10,27 This same site uniquely accepted implantable cardioverterdefibrillators and pacemakers following Canadian guidelines, but also accepted
cardiac arrhythmias, congenital heart disease, and cardiomyopathies, which were
not indicated in national guidelines.8,28 In Ontario, provincial guidelines also cite
“having (a) CVD risk factor(s) only (e.g., hypertension but with no CVD event)” as
an accepted criterion for referral, yet neither site appeared to include this
participant cohort.28 One of the sites in Michigan also veered from national
guidelines by uniquely accepting left ventricular assist devices and peripheral
arterial disease.7 An explanation for the deviation by these CR sites from the
eligibility criteria proposed in guidelines could be that the national guidelines (e.g.,
CACPR and AACVPR) are outdated (i.e., not within the last 5 years) and as such,
the benefit for other participant populations may have since been established
(perhaps even within these individual CR sites), and thus updated endorsement
and guidelines from governing bodies is required.7,8 Furthermore, research is
warranted to better understand why sites in the same country and within the same
province or state would not have identical eligibility criteria. Once within country
nuances are justified, between country differences may be examined and the
impact of CR on outcomes for cohorts of participants with varying referral
indications can be established.
Furthermore, although it is unclear why Ontario sites would not have CVD
risk factor-only participants as part of the CR clientele, it could be speculated that
since CAD is the second leading cause of death in Canada, the capacity of the
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early outpatient CRPs would be quickly surpassed if participants with only CVD
risk factors and no CVD event were referred.3 As these “at risk” individuals would
benefit from CR, they could still be identified at both the Ontario and Michigan sites
and provided with resources to adopt beneficial lifestyle changes at home, such as
improving dietary intake and physical activity. This programming could be
considered “pre-habilitation” and insurance coverage, especially in the United
States could be advocated. In fact, the CR model has been followed to provide
lifestyle interventions to individuals with metabolic syndrome (a group of
cardiometabolic risk factors including, but not limited to hypertension, glucose
intolerance and high blood insulin levels, hyperlipidemia, and obesity) and has
proven to produce positive outcomes by eliminating the prevalence of metabolic
syndrome and the related CVD risk factors in individuals.29–31 Therefore, the
chance of CVD and ultimately CAD is reduced.30,31
Referral Details
A variety of referral procedures were observed across the four sites and
most often included both automatic and paper referrals depending on the point of
referral. Sites had multiple points of referral, including acute care, inpatients at siteaffiliated hospitals, and outpatients at affiliated physician offices. Although beyond
the scope of the current study, future work could explore these procedural
variations and determine those that elicit maximal referral rates. Consideration of
the different health care systems and the related points of referral at each site may
also be crucial as deviations of automatic referral could be more beneficial in
specific health care settings.
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Core Components
None of the sites offered participation incentives, but all may want to
consider implementing incentives as a strategy to increase rates of program
attendance and completion.13,32 The benefit of this was demonstrated when a CRP
at the Mayo Clinic (Rochester, Minnesota, United States) implemented a
motivational program which included participants receiving specific prizes (e.g.,
parking pass, T-shirt, tote bag) after every sixth session attended, and staff
members receiving similar prizes for promoting participant success.32 The median
number of sessions attended increased by three.32 The sites in this study could
design cost-effective incentive programs for their cohorts of participants and test
their effectiveness.
Exercise Training Details
In the current study, all sites conducted an exercise test to guide exerciserelated programming at intake. However, one of the Michigan sites conducted
exercise tests on only 50% of participants. Three of the sites measured maximal
VO2, whereas one of the sites estimated this measurement with submaximal
exercise testing protocols. The utilization of exercise testing could be discussed
among the sites to understand individual rationales for exercise testing and discuss
the merits and disadvantages of existing procedures in CR populations.
ECG-monitoring or telemetry use during exercise occurred across the sites
in Michigan, but not in Ontario. One Michigan site indicated its use for the first three
exercise sessions then discontinuation until clinical need, whereas the other
Michigan site transitioned to discontinuation when insurance approval was granted
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and in the absence of signs and/or symptoms. The slight nuance between the
Michigan sites warrants further examination. It may be worthwhile for the Michigan
sites to consider following the “use as needed” format as per the Ontario-based
sites. This change would require approval from insurance providers, but it may
reduce programming costs and lessen participant burden.
Data Collection Time-Points
All sites collected data at intake and graduation. Three of the sites collected
data from participants at different time points during CR programming, yet only one
of these sites (an Ontario site) collected data that mirrored intake. This
comprehensive assessment was only conducted when warranted. All sites may
want to consider collecting data during programming to determine if individualized
programs need to be adjusted throughout the duration of early outpatient CR
participation to maximize adherence and benefit.
One of the Michigan sites collected data from participants at multiple time
points following graduation (1, 6, and 12 months after graduation, then following
every 6 months thereafter), delivering an assessment similar to that at intake. The
other sites may want to adopt such follow-up procedures, as these align with
national guidelines, and provide valuable information on the maintenance of
benefits.7 As implementation of lifestyle changes diminishes within 3 to 6 months
following early outpatient CR, this may provide insight into the challenges
experienced by graduates and provide a platform to create strategies for
improvement from both a provider and participant perspective.7 Additionally, postgraduation follow-up would be a primitive way of implementing and tracking home-
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based programming for participants following graduation as part of the
maintenance phase.
Staff Members
All sites had a medical director who is a physician. However, there was
variation in the designation of the program director, as well as the number of and
amount of participant interaction with exercise physiologists/kinesiologists,
dietitians, and nurses. These differences may be attributed to the funding that the
programs receive or the capacity the programs have for participants but could
nonetheless be a point of discussion between the sites to determine an ideal
participant to staff ratio. One site had a psychologist, whereas the other three sites
did not, and as such, an appointment with a psychologist is typically provided
following a referral. Considering that psychological and social factors (e.g.,
depression, anxiety, stress) are modifiable CVD risk factors that can negatively
impact disease progression following a cardiac event, perhaps all sites could
consider having a psychologist on staff to eliminate the wait time of referrals.33,34
However, two of the sites without a psychologist did have a social
worker/behaviourist/stress management personnel on staff and the other site
referred participants to these services so this may also assist with psychosocial
management. It is important to recognize that these specialties require substantial
monetary support and may thus not be feasible.
Home-Based Programming
Three of the four sites offered home-based programming to participants, yet
all administered slightly different programs. Innovative program components of
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one of the Michigan-based sites involved live two-way audio and video
conferencing and online presentations for delivery of core components. Thus,
home-programming is yet another area where the sites could converse about
implemented methods. Future work could investigate the strengths and
weaknesses of these protocols as predictors of participant success, while
ascertaining the associated cost implications.
Objective 2: Common and Unique Database Variables
Numerous common and unique variables were identified in the database
variables collected across the four sites.
Variables Collected at Intake
Referral and General Intake
Only the Ontario sites collected the point of referral. As referral rates are
suboptimal in Canada and the United States, the Michigan-based sites may benefit
from collecting this information, with future research exploring the potential
shortcomings of specific referral locations (e.g., inpatient unit, cardiac
diagnostics/intervention unit, physician office).13,14 Similarly, only the Ontario sites
collected date of referral. This is important information for calculating governingbody benchmarks for post-discharge CR enrollment (i.e., Canada - 30 days, United
States - 21 days) and something for all sites to consider collecting.9,10 Strategies
for maximizing referral and achieving mandated benchmarks at all sites could then
be designed, implemented and investigated. Moreover, a unique variable collected
by one of the Michigan sites was previous participation in CR. This variable may
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be of interest to the other sites as well, and future work could determine its impact
on program attendance and completion, as well as clinical outcomes.
Medical History
The database dictionaries varied across the sites in the extent that medical
history related variables were collected at intake, ranging from “essential only” to
“very comprehensive”. All sites collected the event or indication for referral to early
outpatient CR, which is valuable for determining if participants with specific
diagnoses (e.g., CABG) are more likely to participate than others in the modern
era of CR, where CR utilization is endorsed in both countries for an array of
diagnoses.16–18 All sites also collected the diagnoses of hypertension and diabetes,
and prescribed medications. A unique variable collected by one of the Michiganbased sites was the signs and symptoms of a participant’s cardiac condition(s).
This could be beneficial for all sites to collect as an indication of secondary events
that may occur during the exercise training component of CR (that is if approval
for exercise training is granted following the intake assessment). The same
Michigan site uniquely collected gynecological, family, and an extensive
comorbidity history, the latter of which could be beneficial for all sites to collect in
effort to identify and overcome barriers to CR participation and completion (please
see page 130 for additional discussion).
There were no common variables identified among the sites to evaluate the
dietary content and eating habits of participants. One Michigan site collected
information regarding what the participant considered a healthy weight to be for
themselves, previous or current weight-loss programs, previous dietician
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counselling, and motivation, confidence and obstacles to improving dietary intake.
These variables provide value and insight into the anthropometrical measurement
of weight, rather than simply collecting an objective number. Furthermore,
collection of dietary content and eating habits may be useful when referring
participants to nutritional counselling and weight management programs.
Considering these are core components of early outpatient CR in both countries,
all sites may want to collect these variables.7,8
There was inconsistency in how emotional and psychosocial health was
assessed across the sites. Overall, different assessments were employed for
depression and anxiety, with little focus on stress. Future studies could examine
the most efficient method of assessment.
Once again, there is variation in how relative variables for physical activity
or exercise patterns are collected. Due to their broad nature, recommending
specifics on what habitual exercise-related data should be collected across sites
is beyond the scope of this study, and warrants further collaborative investigation
by the sites. Having said that, a unique set of variables collected at one of the
Michigan sites is worth considering for immediate collection across all sites:
“exercise equipment at home” and “membership to a gym”. This information may
inform off-site exercise training options, which is especially important in an era
where hybrid and home-based CR programming is gaining endorsement.35–37
Three sites (the Ontario sites and one Michigan site) collected variables at
intake reflective of alcohol consumption, however a unique variable collected by a
Michigan site was “the motivation to quit drinking alcohol from a 0-10 scale”.
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Identifying current status of consumption and quantifying motivation to change
guides referrals and subsequent CR-related programming, including psychological
and/or nutritional counselling and goal-setting, all representing vital aspects of
early outpatient CR.7,8
Current tobacco smoking status was collected by all sites in the study,
although there was variation in the variables collected across the sites in relation
to details of tobacco use. Future work could aim to determine which of these
assorted variables, if any, predicts success of smoking cessation. This would
streamline data collection and may guide the delivery of tobacco cessation
services.
Demographic Information and Barriers to CR Participation and
Completion
All sites collected a variation of demographic information. When collecting
sex, some sites use the term sex interchangeably with gender. In the modern era
of gender identification, a distinction between the two terms should be made to be
inclusive to all participants. Future studies could examine specific barriers to CR
participation and completion that participants with different gender identities may
experience and/or the potential for increased risk of CVD progression (i.e., novel
findings have suggested that hormone therapy may proliferate CVD risk factors).38
The Muslim religion has previously been identified as a potential barrier that
prevents women from participating in CR, yet only one site (a Michigan-based site)
collected participants’ religions.17,39 Moving forward, the influence of other religions
may be important to explore, and strategies to remove this barrier to CR
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participation and completion can be employed (e.g., women-only exercise training
classes, sex and/or religion-exclusive social support by CR staff members).7,13
Linguistic abilities for non-English native speakers have been identified as
a barrier to CR participation and completion.19,21 The Ontario sites collected this
information, but it may be helpful for the Michigan sites to collect spoken language
of participants as well. Suggested strategies to overcome this barrier to
participation and completion could then be explored, such as providing
supplemental written material in varying languages, having interpreter services, or
having bilingual staff members.7,8 It would, however, be important to determine the
cost-benefit ratio of these interventions.
It is promising that three sites (two Ontario sites and a Michigan site)
collected information on education and occupation, as these are known barriers to
CR participation and completion.15,17,18 A unique variable collected by the Ontario
sites was the participant’s desired occupation status. Goal-setting is a major
aspect of early outpatient CR in both Canada and the United States, and thus the
collection of a participant’s desired occupation status by all sites would be
beneficial. Not only would attainment of desired occupation status provide insight
into whether returning to work is a participant’s priority and adjust programming
accordingly (e.g., offer vocational counselling), it could also serve as a goal to
promote CR attendance by emphasizing that CR participation can increase the
rate of returning to work.7,8 While one Michigan site collected participants’
insurance information, all sites could consider collecting a variable more relevant
to a participant’s financial situation such as annual income. Sites will then be able
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to identify participants who may experience financial burdens that impede CR
participation and completion and then employ strategies to help combat financial
barriers. This is especially important for the Michigan sites, where early outpatient
CR is not entirely covered by funding sources like it is for the sites in Ontario.
Three of the sites (Ontario sites and one Michigan site) collected living
situation and marital status, while the Michigan-based sites collected additional
social support information. Moving forward, all sites may want to obtain collective
social support information, which could be used in a future study to determine
predictors of program completion concomitant to the efficacy of strategies (e.g.,
buddy system, carpooling) designed to increase social support.7
It is promising that the Ontario sites collected travel distance information at
intake. By doing so, increased travel distance as a barrier to participation and
completion can be identified immediately, and strategies (e.g., hybrid or homebased programming) implemented to promote participant success.35–37 Thus, it
would be worthwhile for all sites to consider collecting travel distance and/or travel
time to CR sites.
Physical Evaluation
All sites collected vital signs and anthropometric data in a similar manner,
yet there was variation in how physical status was assessed. It is unclear if these
differences are meaningful, and it is recommended that expert analysis be
conducted to determine the most suitable and efficient variables to collect. A key
difference worth noting pertained to risk of falling, the information of which was
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collected by one Ontario site. Risk of falling is an important safety factor and may
be something all sites may want to collect at intake.
Exercise Test
There were many similar variables collected by the sites with respect to the
exercise test. Three of the sites (two Ontario sites and a Michigan site) collected
the reason for termination. This information may provide a platform for future
research studies investigating common causes of exercise test termination, and
guide future “accommodated” CR programming. A unique variable collected by a
Michigan site was the 6-minute hall walk score. This may be an important testing
consideration for the other sites, at it could be a viable economical option to use
for participants who have limiting factors that prevent completion of maximal and
submaximal exercise tests, but still require an individualized exercise training
programming.7,8,28
Questionnaires
Sites used varying questionnaires to collect information on overall health,
psychological health, physical health, and nutrition. A modern standardized
questionnaire or a battery of questionnaires for CR participants could be fostered
using expertise from across the sites.
Staff Members
Three sites (two Ontario sites and a Michigan site) noted the assigned
participant case manager. This is something to consider for all sites, as
consistency in care may be an important indicator for participant success.
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Variables Collected During Programming
Attendance
All sites in the current study collected attendance data, although the format
differed. For example, the Ontario sites collected attendance rates for specific core
program components, whereas the Michigan sites generalized by collecting the
total number of sessions attended. It may be beneficial for all sites to collect
attendance information across the components and use this information during inprogram evaluation sessions to potentially intervene and employ strategies to
increase attendance for all core components.
Variables Collected at Graduation
The only identical variable collected across sites was an exit exercise test.
One Ontario site and one Michigan site administered graduation assessments that
almost mirrored intake assessment procedures and is something all sites may
want to consider to best evaluate both participant and program success. Similar to
intake, sites collected varying questionnaires on overall health, psychological
health, physical health, and nutrition. Once again, a modern standardized
questionnaire or a battery of questionnaires could be created. A program
evaluation was also administered by one of the Michigan sites, and may be
considered useful by the other sites to evaluate the program quality from a
participant perspective.
One Michigan site collected if participants are having trouble adhering to
the components of CR (e.g., taking prescribed medication, getting regular
exercise, quitting smoking). This provides valuable insight into what adaptations

123

can be made to help the participant better address personal needs and discharge
the participant with the appropriate tools for transition into a less-interactive
maintenance program, or independent management of health behaviours.7,8 Three
sites (two Ontario sites and a Michigan site) collected the reason a participant
graduated or ceased to attend CR (e.g., completed program, insurance, return to
work). As completion rates in Canada and the United States are suboptimal,
collecting this information on why participants are not completing CR is worthwhile.
2.7.2 Phase 2 – Michigan Site Data Analysis
As previously mentioned, the benefits of CR are well-known, yet
participation and completion rates for CR are suboptimal.6,13,14 To date, evidence
suggests that older participants, women, minorities, those with a lower
socioeconomic status (i.e., lower education, unemployed, lower income),
participants having numerous comorbidities, and participants referred for an
indication other than CABG are less likely to participate in and/or complete CR.15–
20,22

Subsequent strategies to overcome these barriers have been suggested13,19,

but future research work is warranted for multiple reasons: 1) there is still a need
to improve participation and completion rates, and 2) available evidence provides
conflicting results, was minimally studied and/or was performed in an older era of
CR programming.
Phase 2 of this study was a first step in addressing these gaps in the
literature. Specifically, this study characterized a participant cohort in a modern era
early outpatient CRP housed on the United States-side of our Great Lakes Central
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Region, and identified participant factors that impacted graduation (i.e., program
completion).
As expected, participants were predominantly Caucasian, and were highly
educated men, yet were older in age, had a greater prevalence of comorbidities,
were not actively employed, and PCI or stent was the primary indication for referral.
Significant predictors of program completion were age and education. Findings are
discussed in detail below. It is important to note that this early work is reflective of
United States-based programming and may not be generalizable to Canadianbased programs, despite close geographical proximity in our Great Lakes Central
Region.
Characterization of the Population
In alignment with previous studies, the participants in this study were
predominantly Caucasian men with higher education (e.g., university).15–17,21,22
Therefore, implementation of strategies to encourage participation of racial
minorities, women, and those with lower levels of education is warranted for this
early outpatient CRP. Contrary to the hypothesis and to previous work, the current
population was on average older, with more comorbidities, not actively employed,
and referred for PCI or stent.15–18 Future research could assess the tactics used
within this CRP that endorsed participation of older participants and those with
more comorbidities and then apply these strategies to other CRPs. Moreover,
strategies to encourage younger participants and those with fewer comorbidities
to participate could also be explored and employed. Additionally, factors impacting
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the participation for different referral indications and actively employed participants
could be explored as well.
Participant Factors and Program Completion
Age
When examining the logistic regression model, each yearly increase in age
was associated with a slight 1.6% increase in the likelihood of graduating.
Previous research has presented older age as a barrier to participation and
completion, but the effect of age may actually be more fluid in regard to CR
participation and completion.15–18 For instance, a recent systematic review of the
factors associated with non-participation in, and dropout from, CRPs showed
contrasting results.17 In essence, drop-out rates varied in the studies examined,
increasing for both older and younger participants.17 Additionally, a recent study in
the United States that utilized data from the Behavioral Risk Factor Surveillance
System (Centres for Disease Control and Prevention; 2005 to 2015) concluded
that participation in CR was more likely for participants who were 65 years of age
or greater compared to younger participants who were 18 to 54 years of age (OR
1.787, 95% CI 1.540 to 2.074, p < 0.0001).40
Despite the findings from this study representing age only modestly
increasing the likelihood of graduating in the logistic regression model, the
prevalence of older participants completing the program may be explained by the
greater time availability they experience, especially as they approach and enter
retirement. As speculated, it was determined that the retired participants were
significantly older in age compared to those who were actively employed. Similarly,

126

the previously mentioned Behavioral Risk Factor Surveillance System study
concluded that retired or self-employed participants were more likely to participate
in an early outpatient CRP, perhaps due to schedule flexibility.40
Therefore, it is important that younger participants, especially those who
have more time commitments (e.g., employment obligations) are identified during
the intake assessment, and that accommodations are made for the participants’
schedules, such as implementing and prescribing hybrid or home-based
programming to encourage participation and completion.35–37 However, this
Michigan site does not offer these alternative forms of CR programming and may
want to discuss with the other Michigan site how to deliver programming and
overcome the associated cost implications for participants in the United States.37
The site could also consider adopting an adaptable on-site program schedule
incorporating early morning, after work, or weekend hours to accommodate a
participant’s commitments; that is if the addition of hours of operation does not
pose a financial burden on the CRP.13
Education
The logistic regression model also revealed that compared to holding a
university education, high school or less education and college/post-secondary
education decreased the likelihood of graduating by 56.5% and 48.2%,
respectively. These findings align with previous research that suggested
participants with higher education are more likely to participate in and/or complete
programming.15,17
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The first possible explanation for these findings is that with higher
education, individuals secure higher paying jobs, leading to financial and
retirement stability.41,42 Therefore, participants with higher education do not
experience the financial barrier to completing CR as they have the monetary funds
to override non-universal healthcare coverage in the United States and to
participate even when retired.41,43
Secondly, the skills obtained from pursuing higher education (e.g., critical
thinking, problem solving, perseverance) are viewed as transferable to taking care
of one’s health.42,44 Therefore, in relation to the current study, graduates may
possess this perception of power to control one’s health.42,44
The intake assessment is crucial in identifying participants who have a lower
education; therefore, education should continue to be collected in the site’s
database. If a participant is lacking the skills to feel in control of one’s health, extra
time can be spent educating the participant on CVD risk factor management and
self-care, and goal-setting can be used to provide the perception of power and
control.7,8
Occupational Status
While more weight should be given to the results of the multivariate
analysis, the findings of the univariate analysis for occupation status and
graduation status are still important to discuss. In this CR cohort, there was a
significantly higher proportion of participants graduating who were retired
compared to non-graduates. These findings are in contrast to the majority of
previous research which suggested that participants who are employed are more
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likely to participate.15,18 As such for this cohort of participants, similar strategies as
those proposed for younger participants (e.g., home-based programming,
adaptable on-site program schedules) could be used to promote program
completion for participants who are not retired, as time-availability is the suspected
barrier to participation and completion.13,35–37
A significantly lower proportion of participants who were medically disabled
graduated compared to those who did not graduate. Despite the low prevalence of
participants who are medically disabled in this cohort, this statistically significant
finding is still worth mentioning because program completion should be maximized
for all participants. As such, these findings align with the majority of previous
research that suggested individuals who are employed are more likely to
participate.15,18 The definition for disability presented by the United States
Government in regards to the benefits provided for individuals with disabilities is:
“the inability to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment(s) which can be expected to result in
death or which has lasted or can be expected to last for a continuous period of not
less than 12 months.”45 Evidently, if a participant has difficulty completing activities
and is very low functioning, transportation to CR and program attendance will be
a burden. Additionally, while participants could be receiving financial support (e.g.,
Social Security, Medicaid, Medicare), the participants are still unemployed so the
financial burden of participating in CR could impact completion as well.15,23
The strategies suggested for encouraging program completion of
participants with a high prevalence of comorbidities (please see below) could also
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be applied to improve completion of participants identified as medically disabled,
such as home-based programming if the participants are homebound.13,35–37
Comorbidities
Notably, comorbidities were trending towards significance as a predictor
variable in the logistic regression. As the data suggested, the proportion of
graduates that had more than two comorbidities was significantly less than the
proportion that did not graduate. These findings align with recent reviews of CR,
and it has been suggested that higher rates of comorbidities (e.g., depression,
stroke, COPD) are related to early drop-out from CR.15,17,46
Unmistakably, CR is modeled to manage CVD risk factors, however the
basis of the model can improve the status of the majority of chronic diseases.47
Therefore, it is important that a participant with multiple comorbidities is
encouraged to stay in CR to learn how to manage one’s health and better one’s
overall HRQoL.48 Conclusively, comorbidities (i.e., chronic diseases) cannot be
treated independently and thus this site should strive to apply the rehabilitation
aspect of CR to all chronic diseases, not solely CVDs. With that said, the intake
assessment is once again vital in flagging participants with a high prevalence of
comorbidities at intake. Notably, this Michigan site collects an extensive list of
comorbidities and should continue this practice.
It is also important to evaluate at intake how CR could be viewed as an
inconvenience for the participant, adding to the participant’s perceived disease
burden. This emphasizes the importance of individualized programs in CR so
participants with multiple comorbidities can have personal goals and preferences
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heard and accounted for with respect to the delivery of care. Another way to reduce
the burden for participants is to ensure coordinated care. It is important that CR
staff members are in communication with other health care providers that are part
of the participant’s overall care plan to provide maximum standard of care
treatment.49 Furthermore, if participants are homebound, perceived burden could
also be reduced by offering adapted or usual home-based programming to
minimize transportation or accessibility issues.13,35,37 Once again, this Michigan
site may want to discuss the logistics of alternative programming with the other
Michigan site.
A statistically significant difference was also observed between age and the
number of comorbidities, suggesting that older participants have more
comorbidities. It is predictable that older aged participants are diagnosed with more
comorbidities, but what is unexplained is the opposite effect that age and
comorbidities have on graduation status, despite participants with greater than two
comorbidities being the oldest aged cohort in this study. It is possible that the
numerous burdens of having multiple comorbidities outweigh the benefit of time
availability acquired with retirement. With multiple comorbidities and the
accumulated impairments, along with the prescription of numerous medications
and the potential negative interactions of medications, participants likely feel
overwhelmed and burdened.50 Having more comorbidities will ultimately reduce a
participant’s functionality and increase frailty, which are important aspects to
consider as well when promoting early outpatient CR participation and
completion.49
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Sex
In contrast, sex did not have a significant association with graduation status.
This is surprising as it is established in the literature that women are less likely to
participate and complete programming.15–20 Despite the non-significant findings
between sex and graduation status, when further examining this cohort of
participants, there are over two times as many men compared to women. With this
said, once women enroll in this early outpatient CRP, they may have the same
probability as men to complete (e.g., within each sex approximately three quarters
of participants completed programming). Therefore, the barriers for women to
complete this program could potentially arise during the referral process and
enrollment stage. There have been numerous barriers suggested that prevent
women from being referred to and enrolling in early outpatient CR, such as lack of
physician endorsement, misconceptions of exercise and CR, and family
obligations.19 However, it is important to identify barriers for this specific cohort of
participants and the impact of local factors to develop equal representation of men
and women within this program.19
Race
Furthermore, race was not significantly associated with graduation status.
Previous research has suggested that Caucasians are more likely to participate,
whereas individuals identifying as a minority prevents participation and/or program
completion.16,21,22 Due to race not having an impact on program completion,
characteristics of this early outpatient CRP that promote participation and
completion of participants who are minorities should be identified and shared with
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other sites that may experience race as a barrier. However, it should be noted that
this cohort of participants was predominantly Caucasian, as discussed earlier,
which could be explained by the location of this site (i.e., the majority of the residing
population is Caucasian). Therefore, the low representation of races other than
Caucasian in this early outpatient CRP may be simply a result of participants who
are another race not residing in the vicinity of the program, and unlike sex, it is not
due to the cohort of participants being uncommonly referred or enrolled to this
CRP.
Referral Indication
In contrast to previous research that suggested participants who had CABG
were more likely to participate and/or complete programming, referral indication
was not associated with graduation status.17,18 These findings indicate that this
early outpatient CRP may decide to focus its energy on overcoming other barriers
to participation and completion of programming. Moreover, if this program
implements specific strategies to foster the participation and completion of all
eligible diagnoses then this information should be further investigated and broadly
shared with other sites with similar participant cohorts and program characteristics.
2.8 Conclusion
This study took an important first step toward establishing a CR model or
models that is/are most efficient for all cohorts of participants in varying Ontario
and Michigan based sites. Through examination of the “granular” details of each
site it was determined that all sites may want to consider implementing specific
program characteristics to maximize participant benefit, such as “pre-habilitation”
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programs for individuals at risk of developing CVD and participation incentives for
those completing early outpatient CR. Moreover, differences between the sites
(e.g., the use of telemetry) warrant further investigation. While changes in program
characteristics should ultimately be adopted to benefit participants, the cost
implications of all program changes need to be considered to minimize financial
burden, especially for Michigan sites. As such, the expertise from all sites should
be leveraged to develop strategies that not only provide participant benefit, but
also cost-efficient solutions.
Nonetheless, strategies may also need to be specific to certain cohorts of
participants, especially those that may have factors that hinder their CR
participation and completion. Therefore, while all sites collected vital information in
their databases regarding participants, certain differences emerged suggesting
that all sites may want to collect aspects such as a participant’s: status of previous
CR participation, extensive comorbidity history, religion, spoken language, desired
occupation status, travel distance, availability of exercise equipment at home or
membership to a gym, and adherence issues with CR components. Additionally,
all sites may want to also consider the importance of collecting all-encompassing
participant data not only at intake and program completion, but during
programming as well.
Through collection of participant information, factors that impede program
completion may be better understood. Using historical participant data from one
site, the current study shed light on characteristics of their participant cohort that
were both expected and unexpected. These insightful findings highlight the benefit
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of conducting a larger scale study with data from all sites. This would not only allow
for within site exploration, but it would foster the ability to examine regional
similarities and differences in CR populations.
It became clear that increasing age and obtaining higher education were
associated with program completion in this cohort, with age only modestly
increasing the likelihood of completing programming. Overall, not all factors in the
logistic regression model were associated with graduation status, therefore other
factors need to be explored (e.g., annual income, insurance coverage,
transportation, travel distance, time-availability, social support). Since sex and
race were not associated with program completion, these findings may suggest
that the site is appropriately providing resources to women and participants who
identify as minorities to complete programming.
Overall, this research laid the foundation for within and between country
comparisons across the four involved sites and can lead preliminary discussions
to strategize the next steps to the development of an ideal CR model or models for
all participants.

135

References
1.

WHO. Cardiovascular diseases (CVDs). World Health Organization.
https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases(cvds). Published 2017. Accessed January 4, 2019.

2.

WHO. The top 10 causes of death. World Health Organization.
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-ofdeath. Published 2018. Accessed January 4, 2019.

3.

Public Health Agency of Canada. Report from the Canadian Chronic
Disease Surveillance System: Heart Disease in Canada, 2018; 2018.
http://publications.gc.ca/collections/collection_2018/aspc-phac/HP35-85-12018-eng.pdf. Accessed January 4, 2019.

4.

Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke
statistics—2018 update: A report from the American Heart Association.
Circulation. 2018;137:e67-e492. doi:10.1161/CIR.0000000000000558.

5.

Hamm LF, Sanderson BK, Ades PA, et al. Core competencies for cardiac
rehabilitation/secondary prevention professionals: 2010 Update. J
Cardiopulm Rehabil Prev. 2011;31:2-10.
doi:10.1097/HCR.0b013e318203999d.

6.

Anderson L, Thompson DR, Oldridge N, et al. Exercise-based cardiac
rehabilitation for coronary heart disease. Cochrane Database Syst Rev.
2016;(1). doi:10.1002/14651858.CD001800.pub3.

136

7.

AACVPR. Guidelines for Cardiac Rehabilitation and Secondary Prevention
Programs. 5th ed. Champaign, Illinois: Human Kinetics; 2013.

8.

CACR. Canadian Guidelines for Cardiac Rehabilitation and Cardiovascular
Disease Prevention: Translating Knowledge into Action. 3rd ed. Winnipeg,
Man.: Canadian Association of Cardiac Rehabilitation; 2009.

9.

Grace SL, Poirier P, Norris CM, Oakes GH, Somanader DS, Suskin N.
Pan-Canadian development of cardiac rehabilitation and secondary
prevention quality indicators. Can J Cardiol. 2014;30:945-948.
doi:10.1016/j.cjca.2014.04.003.

10.

Thomas RJ, Balady G, Banka G, et al. 2018 ACC/AHA clinical performance
and quality measures for cardiac rehabilitation: A report of the American
College of Cardiology/American Heart Association Task Force on
performance measures. Circ Cardiovasc Qual Outcomes. 2018;11:1-29.
doi:10.1161/HCQ.0000000000000037.

11.

Grace SL, Parsons TL, Duhamel TA, Somanader DS, Suskin N. The quality
of cardiac rehabilitation in Canada: A report of the Canadian Cardiac
Rehab Registry. Can J Cardiol. 2014;30:1452-1455.
doi:10.1016/j.cjca.2014.06.016.

137

12.

Pack QR, Squires RW, Lopez-Jimenez F, et al. Participation rates, process
monitoring, and quality improvement among cardiac rehabilitation
programs in the United States: A national survey. J Cardiopulm Rehabil
Prev. 2015;35:173-180. doi:10.1097/HCR.0000000000000108.

13.

Ades PA, Keteyian SJ, Wright JS, et al. Increasing cardiac rehabilitation
participation from 20% to 70%: A road map from the million hearts cardiac
rehabilitation collaborative. Mayo Clin Proc. 2017;92:234-242.
doi:10.1016/j.mayocp.2016.10.014.

14.

Grace SL, Turk-Adawi K, Santiago de Araújo Pio C, Alter DA. Ensuring
cardiac rehabilitation access for the majority of those in need: A call to
action for Canada. Can J Cardiol. 2016;32:S358-S364.
doi:10.1016/j.cjca.2016.07.001.

15.

Ruano-Ravina A, Pena-Gil C, Abu-Assi E, et al. Participation and
adherence to cardiac rehabilitation programs. A systematic review. Int J
Cardiol. 2016;223:436-443. doi:10.1016/j.ijcard.2016.08.120.

16.

Suaya JA, Stason WB, Ades PA, Normand S-LT, Shepard DS. Cardiac
rehabilitation and survival in older coronary patients. J Am Coll Cardiol.
2009;54:25-33. doi:10.1016/j.jacc.2009.01.078.

138

17.

Resurrección DM, Moreno-Peral P, Gómez-Herranz M, et al. Factors
associated with non-participation in and dropout from cardiac rehabilitation
programmes: A systematic review of prospective cohort studies. Eur J
Cardiovasc Nurs. 2019;18:38-47. doi:10.1177/1474515118783157.

18.

Beauchamp A, Worcester M, Ng A, et al. Attendance at cardiac
rehabilitation is associated with lower all-cause mortality after 14 years of
follow-up. Heart. 2013;99:620-625. doi:10.1136/heartjnl-2012-303022.

19.

Supervía M, Medina-Inojosa JR, Yeung C, et al. Cardiac rehabilitation for
women: A systematic review of barriers and solutions. Mayo Clin Proc.
2017;92:565-577. doi:10.1016/j.mayocp.2017.01.002.

20.

Martin B-J, Hauer T, Arena R, et al. Cardiac rehabilitation attendance and
outcomes in coronary artery disease patient. Circulation. 2012;126:677687. doi:10.1161/CIRCULATIONAHA.111.066738.

21.

Midence L, Mola A, Terzic CM, Thomas RJ, Grace SL. Ethnocultural
diversity in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2014;34:437444. doi:10.1097/HCR.0000000000000089.

22.

Valencia HE, Savage PD, Ades PA. Cardiac rehabilitation participation in
underserved populations: Minorities, low socioeconomic, and rural
residents. J Cardiopulm Rehabil Prev. 2011;31:203-210.
doi:10.1097/HCR.0b013e318220a7da.

139

23.

Neubeck L, Freedman SB, Clark AM, Briffa T, Bauman A, Redfern J.
Participating in cardiac rehabilitation: A systematic review and metasynthesis of qualitative data. Eur J Prev Cardiol. 2012;19:494-503.
doi:10.1177/1741826711409326.

24.

Sinnott S-J, Buckley C, O′Riordan D, Bradley C, Whelton H. The effect of
copayments for prescriptions on adherence to prescription medicines in
publicly insured populations; A systematic review and meta-analysis.
Postma M, ed. PLoS ONE. 2013;8:e64914.
doi:10.1371/journal.pone.0064914.

25.

Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive
medications after myocardial infarction. N Engl J Med. 2011;365:20882097. doi:10.1056/NEJMsa1107913.

26.

Keteyian S, Relyea B, Blount M, Bryant S. The design and philosophy of a
hospital- and community-based comprehensive cardiac rehabilitation
program. J Cardiopulm Rehabil Prev. 1985;5:492-495.

27.

Balady GJ, Ades PA, Bittner VA, et al. Referral, enrollment, and delivery of
cardiac rehabilitation/secondary prevention programs at clinical centers
and beyond: A presidential advisory from the American Heart Association.
Circulation. 2011;124:2951-2960. doi:10.1161/CIR.0b013e31823b21e2.

140

28.

CCN. Standards for the Provision of Cardiovascular Rehabilitation in
Ontario.; 2014. https://www.crno.ca/news/23-2014-ccn-standards-for-theprovision-of-cardiovascular-rehabilitation-in-ontario.

29.

Zipes D, Libby P, Bonow R, Mann D, Tomaselli G, Braunwald E.
Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th
ed. Philadelphia, Pennsylvania: Elsevier; 2018.

30.

Walden P, Rubenfire M, Jackson E, Oral E, Jiang Q, Weintraub M.
Assessing the incremental benefit of an extended duration lifestyle
intervention for the components of the metabolic syndrome. Diabetes
Metab Syndr Obes Targets Ther. 2016;9:177-184.
doi:10.2147/DMSO.S94772.

31.

Rubenfire M, Mollo L, Krishnan S, et al. The metabolic fitness program:
Lifestyle modification for the metabolic syndrome using the resources of
cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2011;31:282-289.
doi:10.1097/HCR.0b013e318220a7eb.

32.

Pack QR, Johnson LL, Barr LM, et al. Improving cardiac rehabilitation
attendance and completion through quality improvement activities and a
motivational program. J Cardiopulm Rehabil Prev. 2013;33:153-159.
doi:10.1097/HCR.0b013e31828db386.

141

33.

Cohen BE, Edmondson D, Kronish IM. State of the art review: Depression,
stress, anxiety, and cardiovascular disease. Am J Hypertens.
2015;28:1295-1302. doi:10.1093/ajh/hpv047.

34.

Steptoe A, Kivimäki M. Stress and cardiovascular disease: An update on
current knowledge. Annu Rev Public Health. 2013;34:337-354.
doi:10.1146/annurev-publhealth-031912-114452.

35.

Anderson L, Sharp GA, Norton RJ, et al. Home-based versus centre-based
cardiac rehabilitation. Cochrane Database Syst Rev. 2017;(6).
doi:10.1002/14651858.CD007130.pub4.

36.

Gabelhouse J, Eves N, Grace SL, Reid RC, Caperchione CM. Traditional
versus hybrid outpatient cardiac rehabilitation: A comparison of patient
outcomes. J Cardiopulm Rehabil Prev. 2018;38:231-238.
doi:10.1097/HCR.0000000000000253.

37.

Thomas RJ, Beatty AL, Beckie TM, et al. Home-based cardiac
rehabilitation. J Am Coll Cardiol. 2019;74:133-153.
doi:10.1016/j.jacc.2019.03.008.

38.

Streed CG, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee
M. Cardiovascular disease among transgender adults receiving hormone
therapy: A narrative review. Ann Intern Med. 2017;167:256-267.
doi:10.7326/M17-0577.

142

39.

Chauhan U, Baker D, Lester H, Edwards R. Exploring uptake of cardiac
rehabilitation in a minority ethnic population in England: A qualitative study.
Eur J Cardiovasc Nurs. 2010;9:68-74. doi:10.1016/j.ejcnurse.2009.10.003.

40.

Peters AE, Keeley EC. Trends and dors of participation in cardiac
rehabilitation following acute myocardial infarction: Data from the
Behavioral Risk Factor Surveillance System. J Am Heart Assoc.
2018;7:e007664. doi:10.1161/JAHA.117.007664.

41.

Tamborini CR, Kim C, Sakamoto A. Education and lifetime earnings in the
United States. Demography. 2015;52:1383-1407. doi:10.1007/s13524-0150407-0.

42.

Zajacova A, Lawrence EM. The relationship between education and health:
Reducing disparities through a contextual approach. Annu Rev Public
Health. 2018;39:273-289. doi:10.1146/annurev-publhealth-031816-044628.

43.

Schröder SL, Richter M, Schröder J, Frantz S, Fink A. Socioeconomic
inequalities in access to treatment for coronary heart disease: A systematic
review. Int J Cardiol. 2016;219:70-78. doi:10.1016/j.ijcard.2016.05.066.

44.

Mirowsky J, Ross CE. Education, health, and the default American lifestyle.
J Health Soc Behav. 2015;56:297-306. doi:10.1177/0022146515594814.

143

45.

United States Government. Disability Evaluation Under Social Security.
Social Security Administration.
https://www.ssa.gov/disability/professionals/bluebook/general-info.htm.
Published 2019. Accessed July 24, 2019.

46.

Pardaens S, De Smedt D, De Bacquer D, Willems A-M, Verstreken S, De
Sutter J. Comorbidities and psychosocial characteristics as determinants of
dropout in outpatient cardiac rehabilitation. J Cardiovasc Nurs. 2017;32:1421. doi:10.1097/JCN.0000000000000296.

47.

Arena R, Ozemek C, Laddu D, et al. Applying precision medicine to healthy
living for the prevention and treatment of cardiovascular disease. Curr
Probl Cardiol. 2018;43:448-483. doi:10.1016/j.cpcardiol.2018.06.001.

48.

Listerman J, Bittner V, Sanderson BK, Brown TM. Cardiac rehabilitation
outcomes: Impact of comorbidities and age. J Cardiopulm Rehabil Prev.
2011;31:342-348. doi:10.1097/HCR.0b013e31822f189c.

49.

Holland AE, Lee AL. Precision medicine, healthy living and the complex
patient: Managing the patient with multimorbidity. Prog Cardiovasc Dis.
2019;62:29-33. doi:10.1016/j.pcad.2018.12.010.

50.

Petrillo LA, Ritchie CS. The challenges of symptom management for
patients with multimorbidity in research and practice: A thematic review.
Prog Palliat Care. 2016;24:262-267. doi:10.1080/09699260.2016.1192320.

144

Appendices
Appendix A: Missing Cases
Statistics
Graduation Status
N

Valid
Missing

Gender

Education

Occupation Status

Comorbidities

Referral Indication

Race

1263

1265

1263

1265

1257

1265

1265

2

0

2

0

8

0

0
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Appendix B: Comparison of Graduation Status and Age Results
Group Statistics
N

Graduation Status
Age

Mean

Std. Deviation

Std. Error Mean

Not Graduated

321

60.4704

12.44261

0.69448

Graduated

942

63.2059

11.52182

0.37540

Independent Samples Test
Levene's Test for Equality of Variances

F
Age

Equal variances assumed
Equal variances not assumed

t-test for Equality of Means

Sig.
0.987

t
0.321

df
-3.599

1261

-3.465

519.250
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Sig. (2-tailed)
Mean Difference
0.000
-2.73554
0.001

-2.73554

Std. Error
Difference
0.76018
0.78945

95% Confidence Interval of the
Difference
Lower
Upper
-4.22690

-1.24418

-4.28644

-1.18464

Appendix C: Comparison of Graduation Status and Sex Results
Case Processing Summary
Cases
Valid

Missing

N
Sex * Graduation Status

Percent
1263

N

Total
Percent

99.8%

2

N
0.2%

Percent
1265

100.0%

Sex * Graduation Status Crosstabulation
Graduation Status
Not Graduated
Sex

Men

Count

895

227.5

667.5

895.0

% within Sex

25.4%

74.6%

100.0%

% within Graduation Status

70.7%

70.9%

70.9%

% of Total

18.0%

52.9%

70.9%

0.0

0.0

Standardized Residual
Count

94a

274a

368

93.5

274.5

368.0

% within Sex

25.5%

74.5%

100.0%

% within Graduation Status

29.3%

29.1%

29.1%

7.4%

21.7%

29.1%

0.0

0.0

Expected Count

% of Total
Standardized Residual
Total

Total

668a

Expected Count

Women

Graduated

227a

Count
Expected Count
% within Sex
% within Graduation Status
% of Total

321

942

1263

321.0

942.0

1263.0

25.4%

74.6%

100.0%

100.0%

100.0%

100.0%

25.4%

74.6%

100.0%

Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.

Chi-Square Tests

Value

Asymptotic
Significance (2sided)

df

Pearson Chi-Square

.004a

1

0.947

Continuity Correctionb

0.000

1

1.000

Likelihood Ratio

0.004

1

0.947

Fisher's Exact Test
Linear-by-Linear Association

.004c

N of Valid Cases

1263

1

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 93.53.
b. Computed only for a 2x2 table
c. The standardized statistic is -.067.
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0.947

Exact Sig. (2sided)

Exact Sig. (1sided)

1.000

0.500

1.000

0.500

0.943

0.500

1.000

0.500

Point Probability

0.056

Appendix D: Comparison of Graduation Status and Race Results
Case Processing Summary
Cases
Valid
N
Race * Graduation Status

Missing
Percent

1263

N

Total
Percent

99.8%

N

2

0.2%

Percent
1265

100.0%

Race * Graduation Status Crosstabulation
Graduation Status
Not Graduated
Race

Caucasian

Count

1042

264.8

777.2

1042.0

% within Race

25.3%

74.7%

100.0%

% within Graduation Status

82.2%

82.6%

82.5%

% of Total

20.9%

61.6%

82.5%

-0.1

0.0

Standardized Residual
Count
Expected Count
% within Race

63a

86

64.1

86.0

26.7%

73.3%

100.0%

7.2%

6.7%

6.8%

% of Total

1.8%

5.0%

6.8%

0.2

-0.1

Count

34a

101a

135

34.3

100.7

135.0

% within Race

25.2%

74.8%

100.0%

% within Graduation Status

10.6%

10.7%

10.7%

2.7%

8.0%

10.7%

-0.1

0.0

Expected Count

% of Total
Standardized Residual
Total

23a
21.9

% within Graduation Status

Standardized Residual
Other Race

Total

778a

Expected Count

African American

Graduated

264a

Count
Expected Count
% within Race
% within Graduation Status
% of Total

321

942

1263

321.0

942.0

1263.0

25.4%

74.6%

100.0%

100.0%

100.0%

100.0%

25.4%

74.6%

100.0%

Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.

Chi-Square Tests

Value

Asymptotic
Significance (2sided)

df

Exact Sig. (2sided)

Pearson Chi-Square

.087a

2

0.957

0.958

Likelihood Ratio

0.086

2

0.958

0.958

Fisher's Exact Test

0.125

Linear-by-Linear Association

.003b

1

0.958

N of Valid Cases

1263

Exact Sig. (1sided)

Point Probability

0.950

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 21.86.
b. The standardized statistic is -.052.
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0.960

0.495

0.040

Appendix E: Comparison of Graduation Status and Education Results
Case Processing Summary
Cases
Valid
N

Missing
Percent

Education * Graduation Status

1261

N
99.7%

Total
Percent

4

N

Percent

0.3%

1265

100.0%

Education * Graduation Status Crosstabulation
Graduation Status
Not Graduated
Education

University

Count

633

160.6

472.4

633.0

% within Education

18.3%

81.7%

100.0%

% within Graduation Status

36.3%

54.9%

50.2%

9.2%

41.0%

50.2%

-3.5

2.1

% of Total
Standardized Residual
Count

68a

119b

187

47.5

139.5

187.0

% within Education

36.4%

63.6%

100.0%

% within Graduation Status

21.3%

12.6%

14.8%

5.4%

9.4%

14.8%

3.0

-1.7

Expected Count

% of Total
Standardized Residual
College/Post-Secondary

Count

118a

258b

376

Expected Count

95.4

280.6

376.0

% within Education

31.4%

68.6%

100.0%

% within Graduation Status

36.9%

27.4%

29.8%

9.4%

20.5%

29.8%

2.3

-1.3

% of Total
Standardized Residual
Unknown

Count
Expected Count
% within Education

18a

47a

65

16.5

48.5

65.0

27.7%

72.3%

100.0%

% within Graduation Status

5.6%

5.0%

5.2%

% of Total

1.4%

3.7%

5.2%

0.4

-0.2

Standardized Residual
Total

Total

517b

Expected Count

High School or Less

Graduated

116a

Count
Expected Count
% within Education
% within Graduation Status
% of Total

320

941

1261

320.0

941.0

1261.0

25.4%

74.6%

100.0%

100.0%

100.0%

100.0%

25.4%

74.6%

100.0%

Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.
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Chi-Square Tests

Value

Asymptotic
Significance (2sided)

df

Exact Sig. (2sided)

35.887a

3

0.000

0.000

Likelihood Ratio

35.869

3

0.000

0.000

Fisher's Exact Test

36.034
1

0.000

Pearson Chi-Square

Linear-by-Linear Association
N of Valid Cases

Exact Sig. (1sided)

Point Probability

0.000

20.716b
1261

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 16.49.
b. The standardized statistic is -4.552.
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0.000

0.000

0.000

Appendix F: Comparison of Graduation Status and Occupation Status
Results
Case Processing Summary
Cases
Valid
N
Occupation Status *
Graduation Status

Missing
Percent

1263

N

Total
Percent

99.8%

2

N
0.2%

Occupation Status * Graduation Status Crosstabulation
Graduation Status
Not Graduated
Occupation Status

Active

Count

428a

574

145.9

428.1

574.0

% within Occupation Status

25.4%

74.6%

100.0%

% within Graduation Status

45.5%

45.4%

45.4%

% of Total

11.6%

33.9%

45.4%

0.0

0.0

Standardized Residual
Count

108a

401b

509

129.4

379.6

509.0

% within Occupation Status

21.2%

78.8%

100.0%

% within Graduation Status

33.6%

42.6%

40.3%

8.6%

31.7%

40.3%

-1.9

1.1

Expected Count

% of Total
Standardized Residual
Unemployed

Count

11a

29a

40

10.2

29.8

40.0

% within Occupation Status

27.5%

72.5%

100.0%

% within Graduation Status

3.4%

3.1%

3.2%

% of Total

0.9%

2.3%

3.2%

0.3

-0.2

Expected Count

Standardized Residual
Medically Disabled

Count

37a

46b

83

21.1

61.9

83.0

% within Occupation Status

44.6%

55.4%

100.0%

% within Graduation Status

11.5%

4.9%

6.6%

2.9%

3.6%

6.6%

3.5

-2.0

Expected Count

% of Total
Standardized Residual
Unknown

Count

19a

38a

57

14.5

42.5

57.0

% within Occupation Status

33.3%

66.7%

100.0%

% within Graduation Status

5.9%

4.0%

4.5%

% of Total

1.5%

3.0%

4.5%

1.2

-0.7

Expected Count

Standardized Residual
Total

Total

146a

Expected Count

Retired

Graduated

Count

321

942

1263

321.0

942.0

1263.0

% within Occupation Status

25.4%

74.6%

100.0%

% within Graduation Status

100.0%

100.0%

100.0%

25.4%

74.6%

100.0%

Expected Count

% of Total

Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.
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Percent
1265

100.0%

Chi-Square Tests

Value

Asymptotic
Significance (2sided)

df

Exact Sig. (2sided)

22.786a

4

0.000

0.000

Likelihood Ratio

21.047

4

0.000

0.000

Fisher's Exact Test

21.431

Linear-by-Linear Association

7.320b

1

0.007

Pearson Chi-Square

N of Valid Cases

Exact Sig. (1sided)

Point Probability

0.000

1263

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 10.17.
b. The standardized statistic is -2.705.
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0.007

0.004

0.001

Appendix G: Comparison of Graduation Status and Comorbidities Results
Case Processing Summary
Cases
Valid
N

Missing
Percent

Comorbidities * Graduation
Status

1255

N
99.2%

Total
Percent

10

N

Percent

0.8%

1265

100.0%

Comorbidities * Graduation Status Crosstabulation
Graduation Status
Not Graduated
Comorbidities

>2 Comorbidities

Count

121a

Expected Count

101.1

297.9

399.0

69.7%

100.0%

% within Graduation Status

38.1%

29.7%

31.8%

9.6%

22.2%

31.8%

2.0

-1.2

Count

49a

172a

221

56.0

165.0

221.0

% within Comorbidities

22.2%

77.8%

100.0%

% within Graduation Status

15.4%

18.4%

17.6%

3.9%

13.7%

17.6%

-0.9

0.5

Expected Count

% of Total
Standardized Residual
Count

62a

225a

287

72.7

214.3

287.0

% within Comorbidities

21.6%

78.4%

100.0%

% within Graduation Status

19.5%

24.0%

22.9%

4.9%

17.9%

22.9%

-1.3

0.7

86a

262a

Expected Count

% of Total
Standardized Residual
2 Comorbidities

Count
Expected Count

348

88.2

259.8

348.0

% within Comorbidities

24.7%

75.3%

100.0%

% within Graduation Status

27.0%

28.0%

27.7%

6.9%

20.9%

27.7%

-0.2

0.1

% of Total
Standardized Residual
Total

399

30.3%

Standardized Residual

1 Comorbidity

Total

278b

% within Comorbidities

% of Total

No Comorbidity

Graduated

Count
Expected Count
% within Comorbidities
% within Graduation Status
% of Total

318

937

1255

318.0

937.0

1255.0

25.3%

74.7%

100.0%

100.0%

100.0%

100.0%

25.3%

74.7%

100.0%

Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.
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Chi-Square Tests

Value

Asymptotic
Significance (2sided)

df

Exact Sig. (2sided)

8.607a

3

0.035

0.035

Likelihood Ratio

8.513

3

0.037

0.037

Fisher's Exact Test

8.414
1

0.059

Pearson Chi-Square

Linear-by-Linear Association
N of Valid Cases

Exact Sig. (1sided)

Point Probability

0.038

3.578b
1255

a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 56.00.
b. The standardized statistic is 1.891.
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0.062

0.031

0.004

Appendix H: Comparison of Graduation Status and Referral Indication
Results
Case Processing Summary
Cases
Valid
N
Referral Indication * Graduation
Status

Missing
Percent

1263

N

Total
Percent

99.8%

2

N
0.2%

Percent
1265

100.0%

Chi-Square Tests

Value
Pearson Chi-Square
Likelihood Ratio

Asymptotic
Significance (2sided)

df

Exact Sig. (2sided)

Exact Sig. (1sided)

6.865a

9

0.651

.b

6.867

9

0.651

.b

.

b

Linear-by-Linear Association

.201

c

N of Valid Cases

1263

Fisher's Exact Test

Point Probability

.b
1

a. 2 cells (10.0%) have expected count less than 5. The minimum expected count is 1.27.
b. Cannot be computed because there is insufficient memory.
c. The standardized statistic is .448.

155

0.654

0.660

0.333

0.008

Referral Indication * Graduation Status Crosstabulation
Graduation Status
Not Graduated
Referral Indication

MI

Count
Expected Count

202.1

271.0

74.2%

100.0%

% within Graduation Status

21.8%

21.3%

21.5%

5.5%

15.9%

21.5%

Standardized Residual

0.1

-0.1

Count

89a

222a

311

79.0

232.0

311.0

% within Referral Indication

28.6%

71.4%

100.0%

% within Graduation Status

27.7%

23.6%

24.6%

7.0%

17.6%

24.6%

% of Total
Standardized Residual

1.1

-0.7

Count

38a

147a

185

47.0

138.0

185.0

% within Referral Indication

20.5%

79.5%

100.0%

% within Graduation Status

11.8%

15.6%

14.6%

3.0%

11.6%

14.6%

-1.3

0.8

Expected Count

% of Total
Standardized Residual
Valve Replacement/Repair

Count
Expected Count

100.0%

% within Graduation Status

15.6%

16.7%

16.4%

4.0%

12.4%

16.4%

-0.4

0.2

Count

1a

4a

5

1.3

3.7

5.0

% within Referral Indication

20.0%

80.0%

100.0%

% within Graduation Status

0.3%

0.4%

0.4%

% of Total

0.1%

0.3%

0.4%

-0.2

0.1

8a

18a

26

6.6

19.4

26.0

% within Referral Indication

30.8%

69.2%

100.0%

% within Graduation Status

2.5%

1.9%

2.1%

% of Total

0.6%

1.4%

2.1%

0.5

-0.3

Standardized Residual
Count
Expected Count

Standardized Residual
Count
Expected Count

100.0%

% within Graduation Status

2.5%

1.6%

1.8%

% of Total

0.6%

1.2%

1.8%

0.9

-0.5

Count

14a

36a

50

12.7

37.3

50.0

% within Referral Indication

28.0%

72.0%

100.0%

% within Graduation Status

4.4%

3.8%

4.0%

% of Total

1.1%

2.9%

4.0%

Standardized Residual

0.4

-0.2

Count

35a

122a

157

39.9

117.1

157.0

% within Referral Indication

22.3%

77.7%

100.0%

% within Graduation Status

10.9%

13.0%

12.4%

2.8%

9.7%

12.4%

-0.8

0.5

8a

20a

28

7.1

20.9

28.0

% within Referral Indication

28.6%

71.4%

100.0%

% within Graduation Status

2.5%

2.1%

2.2%

% of Total

0.6%

1.6%

2.2%

0.3

-0.2

% of Total
Standardized Residual
Count
Expected Count

Standardized Residual
Total

23
23.0

65.2%

Expected Count

CABG/Valve
Replacement/Repair

15a
17.2

34.8%

Expected Count

MI/PCI

8a
5.8

% within Referral Indication

Standardized Residual
Heart Failure

207
207.0

75.8%

Expected Count

Other

157a
154.4

24.2%

Standardized Residual

Stable Angina

50a
52.6

% within Referral Indication

% of Total

Heart Transplant

271

68.9
25.8%

Expected Count

CABG

Total

201a

% within Referral Indication

% of Total

PCI/Stent

Graduated

70a

Count
Expected Count

321

942

1263

321.0

942.0

1263.0

% within Referral Indication

25.4%

74.6%

100.0%

% within Graduation Status

100.0%

100.0%

100.0%

25.4%

74.6%

100.0%

% of Total

Each subscript letter denotes a subset of Graduation Status categories whose column proportions do not differ significantly from each other at the .05 level.
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Appendix I: Comparison of Age and Occupation Status Results
Descriptives
Age

N

Mean

Active

574

56.6498

Std. Deviation
10.18199

Retired

Std. Error
0.42499

95% Confidence Interval for Mean
Lower Bound
Upper Bound
55.8151

57.4846

Minimum
21.00

Maximum
91.00

510

71.0118

8.36659

0.37048

70.2839

71.7396

47.00

95.00

Unemployed

40

56.5500

7.74580

1.22472

54.0728

59.0272

40.00

79.00

Medically Disabled

84

53.7738

9.36071

1.02134

51.7424

55.8052

21.00

72.00

Unknown

57

62.4561

11.34849

1.50314

59.4450

65.4673

37.00

87.00

1265

62.5075

11.80894

0.33202

61.8561

63.1589

21.00

95.00

Total

Test of Homogeneity of Variances
Levene Statistic
Age

df1

df2

Sig.

Based on Mean

4.315

4

1260

0.002

Based on Median

4.156

4

1260

0.002

Based on Median and with
adjusted df

4.156

4

1198.310

0.002

Based on trimmed mean

4.228

4

1260

0.002

Robust Tests of Equality of Means
Age
Statistic a
Welch

df1
195.932

a. Asymptotically F distributed.

157

df2
4

153.978

Sig.
0.000

Multiple Comparisons
Dependent Variable:

(I) Occupation Status
Tukey HSD

Age
Mean Difference (IJ)
Active

Retired

Unemployed

-14.36194*

Unemployed

0.09983

Medically Disabled

Retired

-12.7957

1.54081

1.000

-4.1093

4.3089

2.87602

1.10070

0.069

-0.1308

5.8828

Unknown

-5.80631*

1.30849

0.000

-9.3808

-2.2319

Active

14.36194*

0.57336

0.000

12.7957

15.9282

Unemployed

14.46176*

1.54710

0.000

10.2355

18.6880

Medically Disabled

17.23796*

1.10948

0.000

14.2072

20.2688

Unknown

8.55562*

1.31589

0.000

4.9610

12.1503

Active

-0.09983

1.54081

1.000

-4.3089

4.1093

-14.46176*

1.54710

0.000

-18.6880

-10.2355

Unknown
Active

Active

Retired

Unemployed

0.541

-2.1684

7.7208

1.94343

0.020

-11.2151

-0.5972

1.10070

0.069

-5.8828

0.1308

1.10948

0.000

-20.2688

-14.2072

Unemployed

-2.77619

1.81006

0.541

-7.7208

2.1684

Unknown

-8.68233*

1.61690

0.000

-13.0993

-4.2654

Active

5.80631*

1.30849

0.000

2.2319

9.3808

Retired

-8.55562*

1.31589

0.000

-12.1503

-4.9610

Unemployed

5.90614*

1.94343

0.020

0.5972

11.2151

Medically Disabled

8.68233*

1.61690

0.000

4.2654

13.0993

-14.36194*

0.56380

0.000

-15.9025

-12.8214

Unemployed

0.09983

1.29636

1.000

-3.5716

3.7713

Medically Disabled

2.87602

1.10623

0.077

-0.1905

5.9425

Unknown

-5.80631*

1.56207

0.004

-10.1887

-1.4239

Active

14.36194*

0.56380

0.000

12.8214

15.9025

Unemployed

14.46176*

1.27953

0.000

10.8307

18.0929

Medically Disabled

17.23796*

1.08646

0.000

14.2227

20.2532

Unknown

8.55562*

1.54813

0.000

4.2079

12.9033

Active

-0.09983

1.29636

1.000

-3.7713

3.5716

-14.46176*

1.27953

0.000

-18.0929

-10.8307

Retired

Medically Disabled
Unknown
Active

2.77619

1.59470

0.414

-1.6619

7.2143

-5.90614*

1.93891

0.024

-11.2980

-0.5142

-2.87602

1.10623

0.077

-5.9425

0.1905

-17.23796*

1.08646

0.000

-20.2532

-14.2227

Unemployed

-2.77619

1.59470

0.414

-7.2143

1.6619

Unknown

-8.68233*

1.81730

0.000

-13.7270

-3.6376

Active

5.80631*

1.56207

0.004

1.4239

10.1887

Retired

-8.55562*

1.54813

0.000

-12.9033

-4.2079

Unemployed

5.90614*

1.93891

0.024

0.5142

11.2980

Medically Disabled

8.68233*

1.81730

0.000

3.6376

13.7270

Retired

Unknown

1.81006

-2.87602

Retired

Medically Disabled

2.77619
-5.90614*

-17.23796*

Retired

Games-Howell

Upper Bound

-15.9282

Medically Disabled

Unknown

Lower Bound

Sig.
0.000

Retired

Medically Disabled

95% Confidence Interval
Std. Error
0.57336

*. The mean difference is significant at the 0.05 level.
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Appendix J: Comparison of Age and Prevalence of Comorbidities Results
Descriptives
Age

N

Mean

>2 Comorbidities

399

64.2757

Std. Deviation
10.76212

No Comorbidity

221

59.4299

12.32074

1 Comorbidity

287

61.8293

12.51805

2 Comorbidities

350

63.0000

1257

62.5099

Total

Std. Error
0.53878

95% Confidence Interval for Mean
Lower Bound
Upper Bound
63.2165

65.3349

Minimum
21.00

Maximum
95.00

0.82878

57.7965

61.0632

23.00

91.00

0.73892

60.3749

63.2837

23.00

92.00

11.64691

0.62255

61.7756

64.2244

21.00

92.00

11.81095

0.33313

61.8564

63.1635

21.00

95.00

Test of Homogeneity of Variances
Levene Statistic
Age

df1

df2

Sig.

Based on Mean

2.403

3

1253

0.066

Based on Median

2.398

3

1253

0.067

Based on Median and with
adjusted df

2.398

3

1236.336

0.067

Based on trimmed mean

2.384

3

1253

0.068

ANOVA
Age
Sum of Squares
Between Groups

df

Mean Square

3557.654

3

1185.885

Within Groups

171652.471

1253

136.993

Total

175210.126

1256

F

Sig.
8.657

0.000

Multiple Comparisons
Dependent Variable:

(I) Comorbidities
Tukey HSD

Age
Mean Difference (IJ)
>2 Comorbidities

No Comorbidity

1 Comorbidity

2 Comorbidities

Games-Howell

>2 Comorbidities

No Comorbidity

1 Comorbidity

2 Comorbidities

95% Confidence Interval

No Comorbidity

4.84582*

Std. Error
0.98144

1 Comorbidity

2.44642*

2 Comorbidities
>2 Comorbidities

Lower Bound

Sig.

Upper Bound

0.000

2.3211

7.3706

0.90591

0.035

0.1160

4.7769

1.27569

0.85718

0.445

-0.9294

3.4808

-4.84582*

0.98144

0.000

-7.3706

-2.3211

1 Comorbidity

-2.39940

1.04748

0.101

-5.0940

0.2952

2 Comorbidities

-3.57014*

1.00563

0.002

-6.1571

-0.9832

>2 Comorbidities

-2.44642*

0.90591

0.035

-4.7769

-0.1160

No Comorbidity

2.39940

1.04748

0.101

-0.2952

5.0940

2 Comorbidities

-1.17073

0.93206

0.591

-3.5684

1.2270

>2 Comorbidities

-1.27569

0.85718

0.445

-3.4808

0.9294

No Comorbidity

3.57014*

1.00563

0.002

0.9832

6.1571

1 Comorbidity

1.17073

0.93206

0.591

-1.2270

3.5684

No Comorbidity

4.84582*

0.98852

0.000

2.2957

7.3959

1 Comorbidity

2.44642*

0.91448

0.038

0.0900

4.8029

2 Comorbidities

1.27569

0.82332

0.409

-0.8444

3.3958

>2 Comorbidities

-4.84582*

0.98852

0.000

-7.3959

-2.2957

1 Comorbidity

-2.39940

1.11035

0.136

-5.2620

0.4632

2 Comorbidities

-3.57014*

1.03656

0.003

-6.2431

-0.8972

>2 Comorbidities

-2.44642*

0.91448

0.038

-4.8029

-0.0900

No Comorbidity

2.39940

1.11035

0.136

-0.4632

5.2620

2 Comorbidities

-1.17073

0.96621

0.620

-3.6600

1.3186

>2 Comorbidities

-1.27569

0.82332

0.409

-3.3958

0.8444

No Comorbidity

3.57014*

1.03656

0.003

0.8972

6.2431

1 Comorbidity

1.17073

0.96621

0.620

-1.3186

3.6600

*. The mean difference is significant at the 0.05 level.

159

Appendix K: Logistic Regression Model for Graduation Status Results
Case Processing Summary
Unweighted Casesa
Selected Cases

N
Included in Analysis

1253

Percent
99.1

12

0.9

1265

100.0

0

0.0

1265

100.0

Missing Cases
Total
Unselected Cases
Total
a. If weight is in effect, see classification table for the total number of cases.

Dependent Variable Encoding
Internal Value

Original Value
Not Graduated

0

Graduated

1

Categorical Variables Codings
Parameter coding
(1)

Frequency
Occupation Status

Comorbidities

Education

(4)

569

0.000

0.000

0.000

0.000

Retired

508

1.000

0.000

0.000

0.000

Unemployed

40

0.000

1.000

0.000

0.000

Medically Disabled

83

0.000

0.000

1.000

0.000

Unknown

53

0.000

0.000

0.000

1.000

>2 Comorbidities

398

0.000

0.000

0.000

No Comorbidity

220

1.000

0.000

0.000

1 Comorbidity

287

0.000

1.000

0.000

2 Comorbidities

348

0.000

0.000

1.000

University

630

0.000

0.000

0.000

High School or Less

187

1.000

0.000

0.000

College/Post-Secondary

375

0.000

1.000

0.000

61

0.000

0.000

1.000

1032

0.000

0.000

Caucasian
African American

Sex

(3)

Active

Unknown
Race

(2)

86

1.000

0.000

Other Race

135

0.000

1.000

Men

887

0.000

Women

366

1.000

Block 1: Method = Enter
Omnibus Tests of Model Coefficients
Chi-square
Step 1

df

Sig.

Step

63.022

14

0.000

Block

63.022

14

0.000

Model

63.022

14

0.000
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Model Summary
-2 Log likelihood

Step

1354.370a

1

Nagelkerke R
Square

Cox & Snell R Square
0.049

0.072

a. Estimation terminated at iteration number 4 because parameter estimates changed by less than .001.

Classification Tablea
Predicted
Graduation Status
Not Graduated

Observed
Step 1

Graduation Status

Percentage
Correct

Graduated

Not Graduated

17

300

5.4

Graduated

12

924

98.7

Overall Percentage

75.1

a. The cut value is .500

Variables in the Equation
B
Step 1a

S.E.

Wald

df

Sig.

95% C.I.for EXP(B)
Lower
Upper

Exp(B)

Age

0.016

0.007

4.878

1

0.027

1.016

1.002

1.030

Sex(1)

0.128

0.150

0.725

1

0.395

1.136

0.847

1.525

7.634

4

0.106

Occupation Status
Occupation Status(1)

0.166

0.184

0.816

1

0.366

1.181

0.823

1.693

Occupation Status(2)

0.192

0.380

0.254

1

0.614

1.211

0.575

2.553

Occupation Status(3)

-0.539

0.259

4.333

1

0.037

0.583

0.351

0.969

Occupation Status(4)

-0.303

0.333

0.827

1

0.363

0.739

0.384

1.419

7.165

3

0.067

Comorbidities
Comorbidities(1)

0.407

0.207

3.874

1

0.049

1.502

1.002

2.253

Comorbidities(2)

0.440

0.187

5.526

1

0.019

1.553

1.076

2.241

Comorbidities(3)

0.287

0.172

2.788

1

0.095

1.332

0.951

1.866

25.089

3

0.000

Education
Education(1)

-0.832

0.195

18.279

1

0.000

0.435

0.297

0.637

Education(2)

-0.658

0.159

17.223

1

0.000

0.518

0.380

0.707

Education(3)

-0.446

0.330

1.830

1

0.176

0.640

0.335

1.222

1.094

2

0.579

Race
Race(1)

0.277

0.269

1.063

1

0.303

1.319

0.779

2.234

Race(2)

-0.018

0.219

0.007

1

0.935

0.982

0.640

1.508

Constant

0.171

0.442

0.150

1

0.699

1.187

a. Variable(s) entered on step 1: Age, Sex, Occupation Status, Comorbidities, Education, Race.
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